EdTigor personal page - To The Moon

EdTigor

No personal profile

2Follow

2Followers

0Topic

0Badge

2023-03-22

$Credit Bureau Asia(TCU.SI)$

2023-03-22

$Credit Bureau Asia(TCU.SI)$

2022-08-06

Cool

Sorry, the original content has been removed

2022-08-06

[Cool] [Cool]

Sorry, the original content has been removed

2022-08-04

Buy more please Auntie Cathy! [LOL] [smile]

Sorry, the original content has been removed

2022-08-04

Buy more please Auntie Cathy.

Sorry, the original content has been removed

2021-09-12

Oracle is bullish

Sorry, the original content has been removed

2021-09-07

Up up, sky is the limit.

Sorry, the original content has been removed

2021-09-05

Good one.

Beat the market with this quant system that’s very bullish on stocks at record highs

2021-08-30

Thanks

Sorry, the original content has been removed

2021-08-25

Good perspective.

Gundlach: We're running our economy 'like we're not interested in maintaining global reserve currency status'

2021-08-22

Good run

S&P 500 hasn't fallen 5% from a peak in nearly 200 sessions--what that tells market historians

2021-08-13

Wait till it has bounced back up.

Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582116885862894","uuid":"3582116885862894","gmtCreate":1619023712815,"gmtModify":1619023712815,"name":"EdTigor","pinyin":"edtigor","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":2,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.29","exceedPercentage":"80.47%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.23%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9943231640,"gmtCreate":1679471024381,"gmtModify":1679471026355,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","text":"$Credit Bureau Asia(TCU.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943231640","isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943231801,"gmtCreate":1679470999104,"gmtModify":1679471001884,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","text":"$Credit Bureau Asia(TCU.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943231801","isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902799117,"gmtCreate":1659751187241,"gmtModify":1703750140836,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902799117","repostId":"1118235746","repostType":4,"isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902790472,"gmtCreate":1659751151598,"gmtModify":1703750095424,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"[Cool]&nbsp;[Cool]&nbsp;","listText":"[Cool]&nbsp;[Cool]&nbsp;","text":"[Cool] [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902790472","repostId":"1153913928","repostType":4,"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902064450,"gmtCreate":1659615382872,"gmtModify":1705982180747,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Buy more please Auntie Cathy!&nbsp;[LOL]&nbsp;[smile]&nbsp;","listText":"Buy more please Auntie Cathy!&nbsp;[LOL]&nbsp;[smile]&nbsp;","text":"Buy more please Auntie Cathy! [LOL] [smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902064450","repostId":"2256275479","repostType":4,"isVote":1,"tweetType":1,"viewCount":391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902062671,"gmtCreate":1659615085595,"gmtModify":1705982177005,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Buy more please Auntie Cathy.","listText":"Buy more please Auntie Cathy.","text":"Buy more please Auntie Cathy.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902062671","repostId":"2256275479","repostType":4,"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888353722,"gmtCreate":1631442809766,"gmtModify":1676530549105,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Oracle is bullish","listText":"Oracle is bullish","text":"Oracle is bullish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888353722","repostId":"1160482100","repostType":4,"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880056377,"gmtCreate":1631002828599,"gmtModify":1676530439434,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Up up, sky is the limit.","listText":"Up up, sky is the limit.","text":"Up up, sky is the limit.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880056377","repostId":"1190153270","repostType":4,"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814632948,"gmtCreate":1630811166584,"gmtModify":1676530398994,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Good one.","listText":"Good one.","text":"Good one.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/814632948","repostId":"1157895022","repostType":4,"repost":{"id":"1157895022","pubTimestamp":1630810619,"share":"https://ttm.financial/m/news/1157895022?lang=&edition=fundamental","pubTime":"2021-09-05 10:56","market":"us","language":"en","title":"Beat the market with this quant system that’s very bullish on stocks at record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1157895022","media":"MarketWatch","summary":"Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do ","content":"<blockquote>\n <b>Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.</b>\n</blockquote>\n<p>Imagine you had a money-making machine to harvest gains in the stock market while you sat back to enjoy life.</p>\n<p>That’s everyone’s dream, right? Investor Vance Howard thinks he’s found it.</p>\n<p>Howard and his small army of computer programmers atHoward Capital Managementin Roswell, Ga., have a quantitative system that posts great returns.</p>\n<p>His HCM Tactical Growth Fund&nbsp;HCMGX,+0.35%beats its Russell 1000&nbsp;benchmark index and large-blend fund category by 8.5-10.4 percentage points annualized over the past five years, according to Morningstar. That is no small feat, and not only because it has to overcome a 2.22% fee. Beating the market is simply not easy. His HCM Dividend Sector PlusHCMQX,-0.05%) and HCM Income PlusHCMLX,+0.30%funds post similar outperformance.</p>\n<p>There are drawbacks, which I detail below. (Among them: Potentially long stretches of underperformance and regular tax bills.) But first, what can we learn from this winner?</p>\n<p>So-called quants never share all the details of their proprietary systems, but Howard shares a lot, as you’ll see. And this Texas rancher has a lot of good advice based on “horse sense” — not surprising, given his infectious passion for the markets, and his three decades of experience as a pro.</p>\n<p>Here are five lessons, 12 exchange traded funds (ETFs) and four stocks to consider, from a recent interview with him.</p>\n<p><b>Lesson #1: Don’t be emotional</b></p>\n<p>It’s no surprise so many people do poorly in the market. Evolution has programmed us to fail. For survival, we’ve learned to run from things that frightens us. And crave more of things that are pleasurable — like sweets or fats to store calories ahead of what might be a long stretch without food. But in the market, acting on the emotions of fear and greed invariably make us do the wrong thing at the wrong time. Sell at the bottom, buy at the top.</p>\n<p>Likewise, we’re programmed to believe being with the crowd brings safety. If you’re a zebra on the Savanna, you are more likely to get picked off by a predator if you go it alone. The problem here is being part of a crowd — and crowd psychology — dumb us down to a purely emotional level. This is why people in crowds do terrible things they would never do on their own. It doesn’t matter how smart you are. When you join a crowd, you lose a lot of IQ points. Base emotions take over.</p>\n<p>To do well in the market, you have to counteract these tendencies. “One of the biggest mistakes individual investors and money managers make is getting emotional,” says Howard. “Let your emotions go.”</p>\n<p><b>Lesson #2: Have a system and stick to it</b></p>\n<p>To exorcise emotion, have a system. “And don’t second guess it,” says Howard. “This keeps you from letting the pandemic or Afghanistan scare you out of the market.” He calls his system the HCM-BuyLine. It is basically a momentum and trend-following system — which often works well in the markets.</p>\n<p>The HCM-BuyLine basically works like this. First, rather than use the S&amp;P 500SPX,-0.03%or the Dow Jones Industrial AverageDJIA,-0.21%,Howard blends several stock indices to create his own index. Then he uses a moving average that tells him whether the market is in an uptrend or downtrend.</p>\n<p>When the moving average drops 3.5%, he sells 35%. If it drops 6.5%, he sells another 35%. He rarely goes to 100% cash.</p>\n<p>“If the BuyLine is positive, we will stay long no matter what,” he says. “We take all the emotion out of the equation by letting the math decide.”</p>\n<p>Right now, it’s bullish. (More on this below.)</p>\n<p>Your system also has to tell you when to get back in.</p>\n<p>“That’s where most people screw up,” he says. “They get out of the market, and they don’t know when to get back in.” The HCM-BuyLine gives a buy signal when his custom index trades above its moving average for six consecutive sessions, and then goes on to trade above the high hit during those six days.</p>\n<p>You don’t need a system that calls exact market tops or bottoms. Instead, the BuyLine keeps Howard out of down markets 85% of the time, and in for 85% of the good times.</p>\n<p>“If we can do that consistently, we have superior returns and a less stressful life,” he says. “Being all in during a bad tape is no fun.”</p>\n<p>His system is slow to get him out of the market, but quick to get him back in. Not even a 10% correction will necessarily move him out. He’s often buying those pullbacks. Getting back in fast makes sense, because recoveries off bottoms tend to happen fast.</p>\n<p>“The HCM-BuyLine takes all the emotion out of the process,” says Howard.</p>\n<p><b>Lesson #3: Don’t fight the tape</b></p>\n<p>This concept is one of the core pieces of wisdom from Marty Zweig’s classic book, “Winning on Wall Street.”</p>\n<p>“You have to stay on the right side of market,” agrees Howard. “If you try to trade long in a bad market, it is painful.”</p>\n<p>In other words, don’t try to be a hero.</p>\n<p>“Sometimes, not losing money is where you want to be,” he says.</p>\n<p>Likewise, don’t turn cautious just because the market hits new highs — like now. You should love new highs, because it is a sign of market strength that may likely endure.</p>\n<p><b>Lesson #4: Keep it simple</b></p>\n<p>As you’ll see below, Howard doesn’t use esoteric instruments such as derivatives, swaps or index options. He doesn’t even trade foreign stocks or currencies. This is refreshing for individual investors, because we have a harder time accessing those tools.</p>\n<p>“You don’t have to trade crazy stuff,” he says. “You can trade plain-vanilla ETFs and beat everybody out there.”</p>\n<p><b>Lesson #5: How to trade the current market</b></p>\n<p>First, be long.</p>\n<p>“The HCM-BuyLine is very positive. We are 100% in,” says Howard. “The market is broadening out. It is getting pretty exciting. We do not see it turn around any time soon. We are buying pullbacks.”</p>\n<p>One bullish signal is all the cash on the sidelines. “If there is any relief in Covid, we may see a big rally. We may end up with a great fall [season].”</p>\n<p>Howard uses momentum indicators to select stocks and ETFs, too. For sectors he favors the following.</p>\n<p>He likes health care, tradable through the iShares US HealthcareIYH,-0.04%and ProShares Ultra Health CareRXL,+0.12%ETFs. He’s turning more bullish on biotech, which he plays via the iShares Biotechnology ETFIBB,-0.11%.</p>\n<p>He likes consumer discretionary tradable through the iShares US Consumer ServicesIYC,-0.30%,and airlines via US Global JetsJETS,-1.17%.He also likes tech exposure via the Invesco QQQ TrustQQQ,+0.31%,iShares US TechnologyIYW,+0.50%and&nbsp;iShares SemiconductorSOXX,+0.75%.</p>\n<p>He likes small-caps via the Vanguard Small-Cap Growth Index FundVBK,+0.07%.And convertible bonds via SPDR Bloomberg Barclays Convertible SecuritiesCWB,+0.64%and iShares Convertible BondICVT,+0.37%.</p>\n<p>As for individual names, he singles out MicrosoftMSFT,-0.00%and AppleAAPL,+0.42%in tech, as well as Amazon.comAMZN,+0.43%and TeslaTSLA,+0.16%.</p>\n<p>Also consider Howard’s two ETFs: The HCM Defender 100 IndexQQH,+0.62%and HCM Defender 500 IndexLGH,+1.32%.</p>\n<p>He prefers to add to holdings on 1%-3% dips.</p>\n<p><b>A few drawbacks</b></p>\n<p>His HCM Tactical Growth fund has a history of posting two-year stretches of underperformance of 1.5% to 8.8%, since it was launched in 2015. The fund then came roaring back to net the very positive five-year outperformance cited above. Investing in his system can require patience.</p>\n<p>Every manager, including Warren Buffett, can have a stretch of underperformance, says Howard.</p>\n<p>“We are in the odds game,” he says. “Even in the odds game, you can have a bad hand or two thrown at you.”</p>\n<p>Another challenge is the high turnover, which is 140% a year for Tactical Growth. This means Uncle Sam takes a big cut in the good years. So if you buy Howard’s funds, you may want to do so in a tax-protected account.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beat the market with this quant system that’s very bullish on stocks at record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeat the market with this quant system that’s very bullish on stocks at record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-05 10:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.\n\nImagine you had a money-making ...</p>\n\n<a href=\"https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157895022","content_text":"Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.\n\nImagine you had a money-making machine to harvest gains in the stock market while you sat back to enjoy life.\nThat’s everyone’s dream, right? Investor Vance Howard thinks he’s found it.\nHoward and his small army of computer programmers atHoward Capital Managementin Roswell, Ga., have a quantitative system that posts great returns.\nHis HCM Tactical Growth Fund HCMGX,+0.35%beats its Russell 1000 benchmark index and large-blend fund category by 8.5-10.4 percentage points annualized over the past five years, according to Morningstar. That is no small feat, and not only because it has to overcome a 2.22% fee. Beating the market is simply not easy. His HCM Dividend Sector PlusHCMQX,-0.05%) and HCM Income PlusHCMLX,+0.30%funds post similar outperformance.\nThere are drawbacks, which I detail below. (Among them: Potentially long stretches of underperformance and regular tax bills.) But first, what can we learn from this winner?\nSo-called quants never share all the details of their proprietary systems, but Howard shares a lot, as you’ll see. And this Texas rancher has a lot of good advice based on “horse sense” — not surprising, given his infectious passion for the markets, and his three decades of experience as a pro.\nHere are five lessons, 12 exchange traded funds (ETFs) and four stocks to consider, from a recent interview with him.\nLesson #1: Don’t be emotional\nIt’s no surprise so many people do poorly in the market. Evolution has programmed us to fail. For survival, we’ve learned to run from things that frightens us. And crave more of things that are pleasurable — like sweets or fats to store calories ahead of what might be a long stretch without food. But in the market, acting on the emotions of fear and greed invariably make us do the wrong thing at the wrong time. Sell at the bottom, buy at the top.\nLikewise, we’re programmed to believe being with the crowd brings safety. If you’re a zebra on the Savanna, you are more likely to get picked off by a predator if you go it alone. The problem here is being part of a crowd — and crowd psychology — dumb us down to a purely emotional level. This is why people in crowds do terrible things they would never do on their own. It doesn’t matter how smart you are. When you join a crowd, you lose a lot of IQ points. Base emotions take over.\nTo do well in the market, you have to counteract these tendencies. “One of the biggest mistakes individual investors and money managers make is getting emotional,” says Howard. “Let your emotions go.”\nLesson #2: Have a system and stick to it\nTo exorcise emotion, have a system. “And don’t second guess it,” says Howard. “This keeps you from letting the pandemic or Afghanistan scare you out of the market.” He calls his system the HCM-BuyLine. It is basically a momentum and trend-following system — which often works well in the markets.\nThe HCM-BuyLine basically works like this. First, rather than use the S&P 500SPX,-0.03%or the Dow Jones Industrial AverageDJIA,-0.21%,Howard blends several stock indices to create his own index. Then he uses a moving average that tells him whether the market is in an uptrend or downtrend.\nWhen the moving average drops 3.5%, he sells 35%. If it drops 6.5%, he sells another 35%. He rarely goes to 100% cash.\n“If the BuyLine is positive, we will stay long no matter what,” he says. “We take all the emotion out of the equation by letting the math decide.”\nRight now, it’s bullish. (More on this below.)\nYour system also has to tell you when to get back in.\n“That’s where most people screw up,” he says. “They get out of the market, and they don’t know when to get back in.” The HCM-BuyLine gives a buy signal when his custom index trades above its moving average for six consecutive sessions, and then goes on to trade above the high hit during those six days.\nYou don’t need a system that calls exact market tops or bottoms. Instead, the BuyLine keeps Howard out of down markets 85% of the time, and in for 85% of the good times.\n“If we can do that consistently, we have superior returns and a less stressful life,” he says. “Being all in during a bad tape is no fun.”\nHis system is slow to get him out of the market, but quick to get him back in. Not even a 10% correction will necessarily move him out. He’s often buying those pullbacks. Getting back in fast makes sense, because recoveries off bottoms tend to happen fast.\n“The HCM-BuyLine takes all the emotion out of the process,” says Howard.\nLesson #3: Don’t fight the tape\nThis concept is one of the core pieces of wisdom from Marty Zweig’s classic book, “Winning on Wall Street.”\n“You have to stay on the right side of market,” agrees Howard. “If you try to trade long in a bad market, it is painful.”\nIn other words, don’t try to be a hero.\n“Sometimes, not losing money is where you want to be,” he says.\nLikewise, don’t turn cautious just because the market hits new highs — like now. You should love new highs, because it is a sign of market strength that may likely endure.\nLesson #4: Keep it simple\nAs you’ll see below, Howard doesn’t use esoteric instruments such as derivatives, swaps or index options. He doesn’t even trade foreign stocks or currencies. This is refreshing for individual investors, because we have a harder time accessing those tools.\n“You don’t have to trade crazy stuff,” he says. “You can trade plain-vanilla ETFs and beat everybody out there.”\nLesson #5: How to trade the current market\nFirst, be long.\n“The HCM-BuyLine is very positive. We are 100% in,” says Howard. “The market is broadening out. It is getting pretty exciting. We do not see it turn around any time soon. We are buying pullbacks.”\nOne bullish signal is all the cash on the sidelines. “If there is any relief in Covid, we may see a big rally. We may end up with a great fall [season].”\nHoward uses momentum indicators to select stocks and ETFs, too. For sectors he favors the following.\nHe likes health care, tradable through the iShares US HealthcareIYH,-0.04%and ProShares Ultra Health CareRXL,+0.12%ETFs. He’s turning more bullish on biotech, which he plays via the iShares Biotechnology ETFIBB,-0.11%.\nHe likes consumer discretionary tradable through the iShares US Consumer ServicesIYC,-0.30%,and airlines via US Global JetsJETS,-1.17%.He also likes tech exposure via the Invesco QQQ TrustQQQ,+0.31%,iShares US TechnologyIYW,+0.50%and iShares SemiconductorSOXX,+0.75%.\nHe likes small-caps via the Vanguard Small-Cap Growth Index FundVBK,+0.07%.And convertible bonds via SPDR Bloomberg Barclays Convertible SecuritiesCWB,+0.64%and iShares Convertible BondICVT,+0.37%.\nAs for individual names, he singles out MicrosoftMSFT,-0.00%and AppleAAPL,+0.42%in tech, as well as Amazon.comAMZN,+0.43%and TeslaTSLA,+0.16%.\nAlso consider Howard’s two ETFs: The HCM Defender 100 IndexQQH,+0.62%and HCM Defender 500 IndexLGH,+1.32%.\nHe prefers to add to holdings on 1%-3% dips.\nA few drawbacks\nHis HCM Tactical Growth fund has a history of posting two-year stretches of underperformance of 1.5% to 8.8%, since it was launched in 2015. The fund then came roaring back to net the very positive five-year outperformance cited above. Investing in his system can require patience.\nEvery manager, including Warren Buffett, can have a stretch of underperformance, says Howard.\n“We are in the odds game,” he says. “Even in the odds game, you can have a bad hand or two thrown at you.”\nAnother challenge is the high turnover, which is 140% a year for Tactical Growth. This means Uncle Sam takes a big cut in the good years. So if you buy Howard’s funds, you may want to do so in a tax-protected account.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811345164,"gmtCreate":1630292389458,"gmtModify":1676530259389,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811345164","repostId":"1187925169","repostType":4,"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837328499,"gmtCreate":1629858492411,"gmtModify":1676530154093,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Good perspective.","listText":"Good perspective.","text":"Good perspective.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/837328499","repostId":"1180783116","repostType":4,"repost":{"id":"1180783116","pubTimestamp":1629857995,"share":"https://ttm.financial/m/news/1180783116?lang=&edition=fundamental","pubTime":"2021-08-25 10:19","market":"us","language":"en","title":"Gundlach: We're running our economy 'like we're not interested in maintaining global reserve currency status'","url":"https://stock-news.laohu8.com/highlight/detail?id=1180783116","media":"finance.yahoo","summary":"Billionaire bond investor Jeffrey Gundlach, the founder and CEO of $137 billion DoubleLine Capital, ","content":"<p>Billionaire bond investor Jeffrey Gundlach, the founder and CEO of $137 billion DoubleLine Capital, says his number one conviction over several years is that the U.S. dollar will decline as a consequence of current economic policies, resulting in the U.S. losing its sole reserve currency status.</p>\n<p>\"My number one conviction looking forward a number of years — I'm not talking about the next few months at all, I'm talking about several years — is that the dollar is going to go down,\" Gundlach told Yahoo Finance Live in an exclusive interview on Monday afternoon.</p>\n<p>It's Gundlach's view that the \"places to be in the long-term\" are emerging markets and \"non-U.S entities.\" While Gundlach has already rotated into European equities, the investor expects to \"aggressively rotate into emerging markets,\" but notes it's \"too early for that right now.\"</p>\n<p>\"So the dollar is going down is another reason why ultimately — we touched on gold — I think ultimately gold is going to go a lot higher, but it's really in hibernation right now,\" he added.</p>\n<p>The 61-year-old \"Bond King\" later highlighted that the United States' status of the global reserve currency is in jeopardy.</p>\n<p>\"[The] U.S. has enjoyed the status of sole reserve currency globally for decades, and it's an incredible benefit,\" Gundlach said.</p>\n<p><img src=\"https://static.tigerbbs.com/a6efa817bc4a88d150def06c6e65c1c9\" tg-width=\"705\" tg-height=\"470\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">DoubleLine CEO Jeffrey Gundlach is interviewed during a taping of the \"Wall Street Week\" program on the Fox Business Network, in New York, Thursday, May 5, 2016. (AP Photo/Richard Drew)</p>\n<p>He pointed that in the aftermath of the global coronavirus pandemic and lockdowns, China's economy has been \"the strongest economy in the world by far.\" While U.S. GDP has \"bounced back with a lot of consumption, a lot of that consumption is going to China,\" he added.</p>\n<p>\"That's one of the reasons why China has such a strong economy. So, what we're seeing in the United States is starting to fall behind in economic growth. That's not a new thing. That's been going on for a generation, the U.S. falling behind,\" Gundlach said.</p>\n<p>The investor also pointed out that estimates for when China's economy will be the largest \"keep getting pulled forward,\" noting some economists' projections show China's economy will surpass the U.S. by 2028.</p>\n<p>\"We have debt-to-GDP that is fueling the majority of our so-called economic growth. So, is it really economic growth when you borrow money or print money, send checks to people who turn around and buy goods on Amazon in addition to maybe paying down debt and speculating and these goods come in from China?\" Gundlach said.</p>\n<p>He added: \"We're running our economy in a way that is almost like we're not interested in maintaining global reserve currency status or the largest military or global call it superiority or control. As long as we continue to run these policies, and we're running them more and more aggressively, we're not pulling back on them in any way, we are looking at a road map that is clearly headed towards the U.S. losing its sole reserve currency status.\"</p>\n<p>According to Gundlach, with the current economic policies in place, it's \"almost certain\" the U.S. dollar should be going down.</p>\n<p>\"The value of the dollar is so high because we enjoy global reserve currency status, and we don't really respect it enough. We take it for granted, I guess. We seem to take a lot of things for granted these days in the United States relative to how we thought about things in prior decades and generations. And, I believe we are setting the stage for us to, unfortunately… experience the consequences of our actions the way we have been running a non-serious economic program now, really since 1980, but it's really accelerated so much in the past decade and there's no signs of it abetting,\" he said.</p>\n<p>It's Gundlach's view that the U.S. dollar has \"already peaked\" when the U.S. Dollar Index hit 103.</p>\n<p>\"I believe the dollar will take out the lows of the past down cycle. The dollar has been in a series of declining highs for decades — it goes back to the '80s. For that reason, I think when we get to the next break to the lower level, the dollar will go past the most recent low of around 80 and even take out the low of 70. So, I think there's easily 25% downside in the U.S. dollar.\"</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gundlach: We're running our economy 'like we're not interested in maintaining global reserve currency status'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGundlach: We're running our economy 'like we're not interested in maintaining global reserve currency status'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 10:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/jeffrey-gundlach-view-on-the-us-dollar-decline-154813067.html><strong>finance.yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Billionaire bond investor Jeffrey Gundlach, the founder and CEO of $137 billion DoubleLine Capital, says his number one conviction over several years is that the U.S. dollar will decline as a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/jeffrey-gundlach-view-on-the-us-dollar-decline-154813067.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/jeffrey-gundlach-view-on-the-us-dollar-decline-154813067.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180783116","content_text":"Billionaire bond investor Jeffrey Gundlach, the founder and CEO of $137 billion DoubleLine Capital, says his number one conviction over several years is that the U.S. dollar will decline as a consequence of current economic policies, resulting in the U.S. losing its sole reserve currency status.\n\"My number one conviction looking forward a number of years — I'm not talking about the next few months at all, I'm talking about several years — is that the dollar is going to go down,\" Gundlach told Yahoo Finance Live in an exclusive interview on Monday afternoon.\nIt's Gundlach's view that the \"places to be in the long-term\" are emerging markets and \"non-U.S entities.\" While Gundlach has already rotated into European equities, the investor expects to \"aggressively rotate into emerging markets,\" but notes it's \"too early for that right now.\"\n\"So the dollar is going down is another reason why ultimately — we touched on gold — I think ultimately gold is going to go a lot higher, but it's really in hibernation right now,\" he added.\nThe 61-year-old \"Bond King\" later highlighted that the United States' status of the global reserve currency is in jeopardy.\n\"[The] U.S. has enjoyed the status of sole reserve currency globally for decades, and it's an incredible benefit,\" Gundlach said.\nDoubleLine CEO Jeffrey Gundlach is interviewed during a taping of the \"Wall Street Week\" program on the Fox Business Network, in New York, Thursday, May 5, 2016. (AP Photo/Richard Drew)\nHe pointed that in the aftermath of the global coronavirus pandemic and lockdowns, China's economy has been \"the strongest economy in the world by far.\" While U.S. GDP has \"bounced back with a lot of consumption, a lot of that consumption is going to China,\" he added.\n\"That's one of the reasons why China has such a strong economy. So, what we're seeing in the United States is starting to fall behind in economic growth. That's not a new thing. That's been going on for a generation, the U.S. falling behind,\" Gundlach said.\nThe investor also pointed out that estimates for when China's economy will be the largest \"keep getting pulled forward,\" noting some economists' projections show China's economy will surpass the U.S. by 2028.\n\"We have debt-to-GDP that is fueling the majority of our so-called economic growth. So, is it really economic growth when you borrow money or print money, send checks to people who turn around and buy goods on Amazon in addition to maybe paying down debt and speculating and these goods come in from China?\" Gundlach said.\nHe added: \"We're running our economy in a way that is almost like we're not interested in maintaining global reserve currency status or the largest military or global call it superiority or control. As long as we continue to run these policies, and we're running them more and more aggressively, we're not pulling back on them in any way, we are looking at a road map that is clearly headed towards the U.S. losing its sole reserve currency status.\"\nAccording to Gundlach, with the current economic policies in place, it's \"almost certain\" the U.S. dollar should be going down.\n\"The value of the dollar is so high because we enjoy global reserve currency status, and we don't really respect it enough. We take it for granted, I guess. We seem to take a lot of things for granted these days in the United States relative to how we thought about things in prior decades and generations. And, I believe we are setting the stage for us to, unfortunately… experience the consequences of our actions the way we have been running a non-serious economic program now, really since 1980, but it's really accelerated so much in the past decade and there's no signs of it abetting,\" he said.\nIt's Gundlach's view that the U.S. dollar has \"already peaked\" when the U.S. Dollar Index hit 103.\n\"I believe the dollar will take out the lows of the past down cycle. The dollar has been in a series of declining highs for decades — it goes back to the '80s. For that reason, I think when we get to the next break to the lower level, the dollar will go past the most recent low of around 80 and even take out the low of 70. So, I think there's easily 25% downside in the U.S. dollar.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832183047,"gmtCreate":1629598238989,"gmtModify":1676530075985,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Good run","listText":"Good run","text":"Good run","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/832183047","repostId":"2161745814","repostType":4,"repost":{"id":"2161745814","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1629493200,"share":"https://ttm.financial/m/news/2161745814?lang=&edition=fundamental","pubTime":"2021-08-21 05:00","market":"hk","language":"en","title":"S&P 500 hasn't fallen 5% from a peak in nearly 200 sessions--what that tells market historians","url":"https://stock-news.laohu8.com/highlight/detail?id=2161745814","media":"Dow Jones","summary":"It is an unbearable lightness of being for the S&P 500 index.\nThe broad-market measure of a basket o","content":"<p>It is an unbearable lightness of being for the S&amp;P 500 index.</p>\n<p>The broad-market measure of a basket of 500 U.S. stocks has been preternaturally resistant to pullbacks of late, despite concerns about the spread of the highly transmissible delta variant of COVID-19 and worries that the Federal Reserve’s strategy to reduce its bond purchases may be ill-timed.</p>\n<p>Yet, the S&amp;P 500 indexSPX,+0.81%has seen a largely uninterrupted ascent to such a degree that Friday marked the 200th session without a drawdown of 5% or more from a recent peak, making the current stretch of levitation the longest such since 2016, when the market went 404 sessions without falling by at least 5% peak to trough.</p>\n<p><img src=\"https://static.tigerbbs.com/d5d7a23827730d58001a0b40420acd79\" tg-width=\"981\" tg-height=\"437\" width=\"100%\" height=\"auto\">It is extremely rare for the market to enjoy such a period of relative effervescence. Indeed, such lengthy stretches without a 5% pullback or better have occurred on only eight occasions in the S&amp;P 500 index, the attached table shows.</p>\n<p>There clearly are reasons why the market is clambering higher in the recovery from COVID, set againsta daunting wall of worry. Investors are jockeying between areas of the market that are expected to boost revenue and profit faster than the rest of the pack and those that are beaten down and might benefit from a fuller economic rebound from coronavirus.</p>\n<p>Buying on Monday helped the Dow Jones Industrial AverageDJIA,+0.65%and the S&amp;P 500 indexSPX,+0.81%produce their 35th and 49th record all-time closing highs of 2021, respectively. Meanwhile, the Nasdaq Composite IndexCOMP,+1.19%stands a little over 2.5% from its record high put in on Aug. 5.</p>\n<p>There is, of course, a sense that the party for stocks can’t last forever.</p>\n<p>So, how does the market tend to perform in period after such a protracted bullish run?</p>\n<p>The data set is very small but the S&amp;P 500 has mostly climbed on a median basis, falling 1.2% in the following year but producing a median gain of 17.6% in a two-year period and 55% in the ensuing five-year period. The mean average return is better, showing a gain of 6.5%, 27.4% and 64%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/d556c67fc01e330a57abb4c65802c29d\" tg-width=\"964\" tg-height=\"626\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 hasn't fallen 5% from a peak in nearly 200 sessions--what that tells market historians</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 hasn't fallen 5% from a peak in nearly 200 sessions--what that tells market historians\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-21 05:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>It is an unbearable lightness of being for the S&amp;P 500 index.</p>\n<p>The broad-market measure of a basket of 500 U.S. stocks has been preternaturally resistant to pullbacks of late, despite concerns about the spread of the highly transmissible delta variant of COVID-19 and worries that the Federal Reserve’s strategy to reduce its bond purchases may be ill-timed.</p>\n<p>Yet, the S&amp;P 500 indexSPX,+0.81%has seen a largely uninterrupted ascent to such a degree that Friday marked the 200th session without a drawdown of 5% or more from a recent peak, making the current stretch of levitation the longest such since 2016, when the market went 404 sessions without falling by at least 5% peak to trough.</p>\n<p><img src=\"https://static.tigerbbs.com/d5d7a23827730d58001a0b40420acd79\" tg-width=\"981\" tg-height=\"437\" width=\"100%\" height=\"auto\">It is extremely rare for the market to enjoy such a period of relative effervescence. Indeed, such lengthy stretches without a 5% pullback or better have occurred on only eight occasions in the S&amp;P 500 index, the attached table shows.</p>\n<p>There clearly are reasons why the market is clambering higher in the recovery from COVID, set againsta daunting wall of worry. Investors are jockeying between areas of the market that are expected to boost revenue and profit faster than the rest of the pack and those that are beaten down and might benefit from a fuller economic rebound from coronavirus.</p>\n<p>Buying on Monday helped the Dow Jones Industrial AverageDJIA,+0.65%and the S&amp;P 500 indexSPX,+0.81%produce their 35th and 49th record all-time closing highs of 2021, respectively. Meanwhile, the Nasdaq Composite IndexCOMP,+1.19%stands a little over 2.5% from its record high put in on Aug. 5.</p>\n<p>There is, of course, a sense that the party for stocks can’t last forever.</p>\n<p>So, how does the market tend to perform in period after such a protracted bullish run?</p>\n<p>The data set is very small but the S&amp;P 500 has mostly climbed on a median basis, falling 1.2% in the following year but producing a median gain of 17.6% in a two-year period and 55% in the ensuing five-year period. The mean average return is better, showing a gain of 6.5%, 27.4% and 64%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/d556c67fc01e330a57abb4c65802c29d\" tg-width=\"964\" tg-height=\"626\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","OEX":"标普100","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","SH":"标普500反向ETF",".SPX":"S&P 500 Index","SDS":"两倍做空标普500ETF","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161745814","content_text":"It is an unbearable lightness of being for the S&P 500 index.\nThe broad-market measure of a basket of 500 U.S. stocks has been preternaturally resistant to pullbacks of late, despite concerns about the spread of the highly transmissible delta variant of COVID-19 and worries that the Federal Reserve’s strategy to reduce its bond purchases may be ill-timed.\nYet, the S&P 500 indexSPX,+0.81%has seen a largely uninterrupted ascent to such a degree that Friday marked the 200th session without a drawdown of 5% or more from a recent peak, making the current stretch of levitation the longest such since 2016, when the market went 404 sessions without falling by at least 5% peak to trough.\nIt is extremely rare for the market to enjoy such a period of relative effervescence. Indeed, such lengthy stretches without a 5% pullback or better have occurred on only eight occasions in the S&P 500 index, the attached table shows.\nThere clearly are reasons why the market is clambering higher in the recovery from COVID, set againsta daunting wall of worry. Investors are jockeying between areas of the market that are expected to boost revenue and profit faster than the rest of the pack and those that are beaten down and might benefit from a fuller economic rebound from coronavirus.\nBuying on Monday helped the Dow Jones Industrial AverageDJIA,+0.65%and the S&P 500 indexSPX,+0.81%produce their 35th and 49th record all-time closing highs of 2021, respectively. Meanwhile, the Nasdaq Composite IndexCOMP,+1.19%stands a little over 2.5% from its record high put in on Aug. 5.\nThere is, of course, a sense that the party for stocks can’t last forever.\nSo, how does the market tend to perform in period after such a protracted bullish run?\nThe data set is very small but the S&P 500 has mostly climbed on a median basis, falling 1.2% in the following year but producing a median gain of 17.6% in a two-year period and 55% in the ensuing five-year period. The mean average return is better, showing a gain of 6.5%, 27.4% and 64%, respectively.","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894582074,"gmtCreate":1628839616898,"gmtModify":1676529870978,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Wait till it has bounced back up.","listText":"Wait till it has bounced back up.","text":"Wait till it has bounced back up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/894582074","repostId":"2158225219","repostType":4,"repost":{"id":"2158225219","pubTimestamp":1628819431,"share":"https://ttm.financial/m/news/2158225219?lang=&edition=fundamental","pubTime":"2021-08-13 09:50","market":"us","language":"en","title":"Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?","url":"https://stock-news.laohu8.com/highlight/detail?id=2158225219","media":"Motley Fool","summary":"One particular group of stocks is overrepresented among the exchange's biggest losers this year. That's an important detail.","content":"<p>If you're like many other investors, your search for bargain stocks starts with names that have been severely sold off. As well it should. The market is capable of going to extremes at times, devaluing names only to revalue them again just a short time later. You know the practice by its more familiar name, \"buying the dip.\" The bigger the dip, the better the bargain.</p>\n<p>As veteran investors can attest, however, a stock that's been up-ended isn't inherently a stock that's ready for a recovery. Sometimes, a steep sell-off is exactly what's implied.</p>\n<p>It's the dilemma anyone looking at this year's biggest losers among Nasdaq-listed stocks is facing, as usual. This time around though, there's an additional curious nuance. Most of these losers are in the exact same industry, and have been crushed for the exact same reasons.</p>\n<h2>One too many headwinds</h2>\n<p>For the record, excluding always-volatile small caps and micro caps, the five biggest losers on the Nasdag this year are (with losses respectively ranging from -65% to -56%) <a href=\"https://laohu8.com/S/POSH\">Poshmark, Inc.</a>, <a href=\"https://laohu8.com/S/ACAD\">ACADIA Pharmaceuticals</a>, <a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a>, <a href=\"https://laohu8.com/S/ARVL\">Arrival</a>, and <a href=\"https://laohu8.com/S/FOLD\">Amicus Therapeutics</a>.</p>\n<p><b>It's difficult to ignore that biotech stocks feature prominently among these most severe laggards.</b></p>\n<p>And this theme only solidifies as you look deeper into 2021's worst-to-date performers among the Nasdaq's larger listings. Biotech names <a href=\"https://laohu8.com/S/SRPT\">Sarepta Therapeutics</a> and <a href=\"https://laohu8.com/S/TGTX\">TG Therapeutics</a> claim the sixth and seventh spots from the bottom, down 54% and 53% so far this year.</p>\n<p><b>Can there be a rebound for biotech stocks?</b></p>\n<p>It's a detail worth noting as odds are good that any recovery any of them manage to make from here is likely going to be part of a groupwide rebound. Such a rebound won't be particularly easy to come by, however, for a handful of reasons.</p>\n<p>Chief among reasons it will be hard to recover is sheer circumstance.</p>\n<p><img src=\"https://static.tigerbbs.com/7c680dca85708f2eaaee3bcb174a2eff\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Vaccine race:</b> You may recall a bunch of biotech stocks logged stellar performance around the middle of last year, shortly after the COVID-19 contagion turned into a global pandemic. The world didn't know which player would come up with a vaccine or treatment (or even a test) first, so investors simply made bets on a variety of names in the business... including many of the ones listed above. Once <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>, <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>, and&nbsp;<a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a> essentially won that race though, investors lost the will to stick with other entries.</p>\n<p>The dynamic has been particularly painful for shareholders of <a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a>, which just went public in December, seemingly to capitalize on the vaccine mania that had already peaked. Its shares are now below their IPO price of $17, and well below the stock's December peak near $72.</p>\n<p><b>Recent FTC stance on pharmaceutical mergers</b>: That's not the only thing working against the industry, however, and smaller biotech names in particular. Much of the entire sector's recent weakness also coincides with the Federal Trade Commission's (FTC) creation of a global task force assembled in March to \"build a new approach to pharmaceutical mergers.\"</p>\n<p>It's not clear how much authority this working group will wield. But, in that the announcement made a point of mentioning \"skyrocketing drug prices and ongoing concerns about anticompetitive conduct in the industry,\" it is clear there's a brewing risk to the entire business of drug development.</p>\n<p>It's also worth mentioning that more than a few biotech start-ups are tacitly hoping to get bought out at their inception, with investors quietly hoping for the same. This is going to be a more difficult, less rewarding prospect if the FTC-led efforts are effective.</p>\n<p><b>Legislative changes and regulations:</b> Then there's the even-more philosophical argument that the entire industry is on the verge of running back into the legislative and regulatory buzz saw.</p>\n<p>It's a recurring story. The business usually emerges from such scrutiny unscathed. Indeed, the fact that not many people balked at the $56,000 price tag for <a href=\"https://laohu8.com/S/BIIB\">Biogen</a> recently approved Alzheimer's drug Aduhelm tacitly says drugmakers remain completely in control of their pricing policies... even prices charged to Medicare.</p>\n<p>With a new presidential administration in place, though, proposed legislation like the bills Senator Bernie Sanders and other Democrats unveiled in March -- aimed at lowering drug prices for the government as well as for individuals -- are given another fighting chance.</p>\n<p>Sooner or later, one of these will slip through. And then another. And then another. It's a risk to many smaller biotech developers, which frequently count on high prices for relatively unique therapies.</p>\n<h2>To buy, or not to buy?</h2>\n<p>Fine, but don't these huge pullbacks still make these particular biotech names compelling prospects despite all their challenges?</p>\n<p>Not really.</p>\n<p>To be fair, there's nothing about any cost-curbing prospect or a now-meaningless coronavirus vaccine race that supersedes any of these aforementioned companies' stories. And in the world of biotech, stories about a drug's potential readily substitute for sales and earnings.</p>\n<p>Identifying winning drug developments and looking past misguided research and development is still a key part of the biotech investing game. As of right now, however, the collective overhang is just too much for even the very best biotech stories to break through.</p>\n<p>Some breakthroughs will happen, mind you. We just don't know which names will be the ones best positioned to overcome the headwind and adequately reward shareholders for the risk being taken. It's a headwind that could blow for a few more weeks, if not a few more months.</p>\n<p>The bigger takeaway: Always keep tabs on the market environment and its key themes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 09:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/12/is-it-time-to-buy-5-of-the-nasdaqs-worst-performin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you're like many other investors, your search for bargain stocks starts with names that have been severely sold off. As well it should. The market is capable of going to extremes at times, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/12/is-it-time-to-buy-5-of-the-nasdaqs-worst-performin/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"POSH":"Poshmark, Inc.","ACAD":"阿卡迪亚","FOLD":"爱美医疗","ABCL":"AbCellera Biologics"},"source_url":"https://www.fool.com/investing/2021/08/12/is-it-time-to-buy-5-of-the-nasdaqs-worst-performin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158225219","content_text":"If you're like many other investors, your search for bargain stocks starts with names that have been severely sold off. As well it should. The market is capable of going to extremes at times, devaluing names only to revalue them again just a short time later. You know the practice by its more familiar name, \"buying the dip.\" The bigger the dip, the better the bargain.\nAs veteran investors can attest, however, a stock that's been up-ended isn't inherently a stock that's ready for a recovery. Sometimes, a steep sell-off is exactly what's implied.\nIt's the dilemma anyone looking at this year's biggest losers among Nasdaq-listed stocks is facing, as usual. This time around though, there's an additional curious nuance. Most of these losers are in the exact same industry, and have been crushed for the exact same reasons.\nOne too many headwinds\nFor the record, excluding always-volatile small caps and micro caps, the five biggest losers on the Nasdag this year are (with losses respectively ranging from -65% to -56%) Poshmark, Inc., ACADIA Pharmaceuticals, AbCellera Biologics, Arrival, and Amicus Therapeutics.\nIt's difficult to ignore that biotech stocks feature prominently among these most severe laggards.\nAnd this theme only solidifies as you look deeper into 2021's worst-to-date performers among the Nasdaq's larger listings. Biotech names Sarepta Therapeutics and TG Therapeutics claim the sixth and seventh spots from the bottom, down 54% and 53% so far this year.\nCan there be a rebound for biotech stocks?\nIt's a detail worth noting as odds are good that any recovery any of them manage to make from here is likely going to be part of a groupwide rebound. Such a rebound won't be particularly easy to come by, however, for a handful of reasons.\nChief among reasons it will be hard to recover is sheer circumstance.\n\nImage source: Getty Images.\nVaccine race: You may recall a bunch of biotech stocks logged stellar performance around the middle of last year, shortly after the COVID-19 contagion turned into a global pandemic. The world didn't know which player would come up with a vaccine or treatment (or even a test) first, so investors simply made bets on a variety of names in the business... including many of the ones listed above. Once Pfizer, Moderna, Inc., and Johnson & Johnson essentially won that race though, investors lost the will to stick with other entries.\nThe dynamic has been particularly painful for shareholders of AbCellera Biologics, which just went public in December, seemingly to capitalize on the vaccine mania that had already peaked. Its shares are now below their IPO price of $17, and well below the stock's December peak near $72.\nRecent FTC stance on pharmaceutical mergers: That's not the only thing working against the industry, however, and smaller biotech names in particular. Much of the entire sector's recent weakness also coincides with the Federal Trade Commission's (FTC) creation of a global task force assembled in March to \"build a new approach to pharmaceutical mergers.\"\nIt's not clear how much authority this working group will wield. But, in that the announcement made a point of mentioning \"skyrocketing drug prices and ongoing concerns about anticompetitive conduct in the industry,\" it is clear there's a brewing risk to the entire business of drug development.\nIt's also worth mentioning that more than a few biotech start-ups are tacitly hoping to get bought out at their inception, with investors quietly hoping for the same. This is going to be a more difficult, less rewarding prospect if the FTC-led efforts are effective.\nLegislative changes and regulations: Then there's the even-more philosophical argument that the entire industry is on the verge of running back into the legislative and regulatory buzz saw.\nIt's a recurring story. The business usually emerges from such scrutiny unscathed. Indeed, the fact that not many people balked at the $56,000 price tag for Biogen recently approved Alzheimer's drug Aduhelm tacitly says drugmakers remain completely in control of their pricing policies... even prices charged to Medicare.\nWith a new presidential administration in place, though, proposed legislation like the bills Senator Bernie Sanders and other Democrats unveiled in March -- aimed at lowering drug prices for the government as well as for individuals -- are given another fighting chance.\nSooner or later, one of these will slip through. And then another. And then another. It's a risk to many smaller biotech developers, which frequently count on high prices for relatively unique therapies.\nTo buy, or not to buy?\nFine, but don't these huge pullbacks still make these particular biotech names compelling prospects despite all their challenges?\nNot really.\nTo be fair, there's nothing about any cost-curbing prospect or a now-meaningless coronavirus vaccine race that supersedes any of these aforementioned companies' stories. And in the world of biotech, stories about a drug's potential readily substitute for sales and earnings.\nIdentifying winning drug developments and looking past misguided research and development is still a key part of the biotech investing game. As of right now, however, the collective overhang is just too much for even the very best biotech stories to break through.\nSome breakthroughs will happen, mind you. We just don't know which names will be the ones best positioned to overcome the headwind and adequately reward shareholders for the risk being taken. It's a headwind that could blow for a few more weeks, if not a few more months.\nThe bigger takeaway: Always keep tabs on the market environment and its key themes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":880056377,"gmtCreate":1631002828599,"gmtModify":1676530439434,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Up up, sky is the limit.","listText":"Up up, sky is the limit.","text":"Up up, sky is the limit.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880056377","repostId":"1190153270","repostType":4,"repost":{"id":"1190153270","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631002085,"share":"https://ttm.financial/m/news/1190153270?lang=&edition=fundamental","pubTime":"2021-09-07 16:08","market":"us","language":"en","title":"Sea reached record high in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1190153270","media":"Tiger Newspress","summary":"(Sept 7) Sea reached record high in pre-market trading Tuesday.\nSea Ltd's Shopee is preparing to lau","content":"<p>(Sept 7)&nbsp;Sea reached record high in pre-market trading&nbsp;Tuesday.</p>\n<p><img src=\"https://static.tigerbbs.com/a4e4b0288d320c178ce3ce27e45bdb98\" tg-width=\"1057\" tg-height=\"527\" referrerpolicy=\"no-referrer\">Sea Ltd's Shopee is preparing to launch in Poland and is currently recruiting sellers, two company sources with knowledge of the matter told Reuters.</p>\n<p>The move will be the first expansion into European e-commerce for the $190 billion Singapore-headquartered technology group, whose gaming arm Garena is already active in the region.</p>\n<p>Shopee is simultaneously preparing to launch in India, Reuters reported last week, after aggressively expanding in Latin America since earlier this year.</p>\n<p>One of the sources told Reuters that Shopee is cautiously scaling up its global expansion by testing out possible new markets.</p>\n<p>The two sources, who requested anonymity because they were not authorised to speak to media, said Shopee will also launch in Argentina in the coming months.</p>\n<p>The firm is already the dominant player in e-commerce in Southeast Asia, according to market researchers, bringing in $1.2 billion globally in revenue for the quarter ending June 30.</p>\n<p>Polish news website Wiadomoscihandlowe.pl first reported the Shopee expansion into Poland. Sea did not immediately answer a Reuters request for comment.</p>\n<p>Market research firm Euromonitor estimates the Polish e-commerce market to be worth 16 billion euros ($19 billion), with significant room for growth compared to Western countries.</p>\n<p>Amazon launched its local website this year, while the biggest home e-commerce firm Allegro is ramping up installation of its own parcel lockers.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea reached record high in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea reached record high in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-07 16:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 7)&nbsp;Sea reached record high in pre-market trading&nbsp;Tuesday.</p>\n<p><img src=\"https://static.tigerbbs.com/a4e4b0288d320c178ce3ce27e45bdb98\" tg-width=\"1057\" tg-height=\"527\" referrerpolicy=\"no-referrer\">Sea Ltd's Shopee is preparing to launch in Poland and is currently recruiting sellers, two company sources with knowledge of the matter told Reuters.</p>\n<p>The move will be the first expansion into European e-commerce for the $190 billion Singapore-headquartered technology group, whose gaming arm Garena is already active in the region.</p>\n<p>Shopee is simultaneously preparing to launch in India, Reuters reported last week, after aggressively expanding in Latin America since earlier this year.</p>\n<p>One of the sources told Reuters that Shopee is cautiously scaling up its global expansion by testing out possible new markets.</p>\n<p>The two sources, who requested anonymity because they were not authorised to speak to media, said Shopee will also launch in Argentina in the coming months.</p>\n<p>The firm is already the dominant player in e-commerce in Southeast Asia, according to market researchers, bringing in $1.2 billion globally in revenue for the quarter ending June 30.</p>\n<p>Polish news website Wiadomoscihandlowe.pl first reported the Shopee expansion into Poland. Sea did not immediately answer a Reuters request for comment.</p>\n<p>Market research firm Euromonitor estimates the Polish e-commerce market to be worth 16 billion euros ($19 billion), with significant room for growth compared to Western countries.</p>\n<p>Amazon launched its local website this year, while the biggest home e-commerce firm Allegro is ramping up installation of its own parcel lockers.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190153270","content_text":"(Sept 7) Sea reached record high in pre-market trading Tuesday.\nSea Ltd's Shopee is preparing to launch in Poland and is currently recruiting sellers, two company sources with knowledge of the matter told Reuters.\nThe move will be the first expansion into European e-commerce for the $190 billion Singapore-headquartered technology group, whose gaming arm Garena is already active in the region.\nShopee is simultaneously preparing to launch in India, Reuters reported last week, after aggressively expanding in Latin America since earlier this year.\nOne of the sources told Reuters that Shopee is cautiously scaling up its global expansion by testing out possible new markets.\nThe two sources, who requested anonymity because they were not authorised to speak to media, said Shopee will also launch in Argentina in the coming months.\nThe firm is already the dominant player in e-commerce in Southeast Asia, according to market researchers, bringing in $1.2 billion globally in revenue for the quarter ending June 30.\nPolish news website Wiadomoscihandlowe.pl first reported the Shopee expansion into Poland. Sea did not immediately answer a Reuters request for comment.\nMarket research firm Euromonitor estimates the Polish e-commerce market to be worth 16 billion euros ($19 billion), with significant room for growth compared to Western countries.\nAmazon launched its local website this year, while the biggest home e-commerce firm Allegro is ramping up installation of its own parcel lockers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902790472,"gmtCreate":1659751151598,"gmtModify":1703750095424,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"[Cool]&nbsp;[Cool]&nbsp;","listText":"[Cool]&nbsp;[Cool]&nbsp;","text":"[Cool] [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902790472","repostId":"1153913928","repostType":4,"repost":{"id":"1153913928","pubTimestamp":1659741524,"share":"https://ttm.financial/m/news/1153913928?lang=&edition=fundamental","pubTime":"2022-08-06 07:18","market":"us","language":"en","title":"S&P 500 Ends Down As Jobs Data Rekindles Rate Hike Fear","url":"https://stock-news.laohu8.com/highlight/detail?id=1153913928","media":"StreetInsider","summary":"TheS&P500 ended lower on Friday, weighed down by Tesla and other technology-related stocks after a s","content":"<html><head></head><body><p>TheS&amp;P500 ended lower on Friday, weighed down by Tesla and other technology-related stocks after a solid jobs report torpedoed recent optimism that the Federal Reserve might let up its aggressive campaign to reign in decades-high inflation.</p><p>Data showed U.S. employers hired far more workers than expected in July, the 19th straight month of payrolls expansion, with the unemployment rate falling to a pre-pandemic low of 3.5%.</p><p>The report added to recent data painting an upbeat picture of the world&#39;s largest economy after it contracted in the first half of the year. That deflated investors&#39; expectations that the Fed might let up in its series of rate hikes aimed at cooling the economy.</p><p>&#34;This is all about the Fed. A very strong jobs report like we had puts pressure on the Fed to tighten for longer,&#34; said Adam Sarhan, chief executive of 50 Park Investments. &#34;The market is scared the Fed is going to overshoot again. If they tighten too sharply and too long, that&#39;s going to cause a hard landing, a deep recession.&#34;</p><p>Tesla tumbled 6.6% and weighed heavily on the S&amp;P 500 and Nasdaq. Facebook-owner Meta Platforms lost 2% and Amazon fell 1.2%, also pulling down the index.</p><p>U.S. Treasury yields climbed as odds increased of a 75-basis-point interest rate hike in September. That helped bank stocks, withJPMorganrising 3%, and helping the Dow Jones Industrial Average stay in positive territory.</p><p>Focus now shifts to inflation data due next week, with U.S. annual consumer prices expected to jump by 8.7% in July after a 9.1% rise in June.</p><p>Several policymakers have this week stuck to an aggressive policy tightening stance until they see strong and long-lasting evidence that inflation was trending toward the Fed&#39;s 2% goal.</p><p>Surging inflation, the war in Ukraine, Europe&#39;s energy crisis and COVID-19 flare-ups in China have rattled investors this year.</p><p>A largely upbeat second-quarter earnings season has helped the S&amp;P 500 bounce back by about 13% from its mid-June lows after a rough first-half performance.</p><p>The S&amp;P 500 declined 0.16% to end the session at 4,145.19 points.</p><p>The Nasdaq declined 0.50% to 12,657.56 points, while the Dow Jones Industrial Average rose 0.23% to 32,803.47 points.</p><p>For the week, the S&amp;P 500 rose 0.4%, the Dow fell 0.1% and the Nasdaq added 2.2%.</p><p>Lyft Inc surged almost 17% after the ride-hailing firm forecast an adjusted operating profit of $1 billion for 2024 after posting record quarterly earnings.</p><p>Advancing issues outnumbered falling ones within the S&amp;P 500 by a 1.3-to-1 ratio.</p><p>The S&amp;P 500 posted four new highs and 30 new lows; the Nasdaq recorded 60 new highs and 38 new lows.</p><p>Volume on U.S. exchanges was relatively light, with 10.6 billion shares traded, compared to an average of 10.8 billion shares over the previous 20 sessions.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Ends Down As Jobs Data Rekindles Rate Hike Fear</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Ends Down As Jobs Data Rekindles Rate Hike Fear\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-06 07:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/ETFs/S%26P+500+ends+down+as+jobs+data+rekindles+rate+hike+fear/20422400.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheS&P500 ended lower on Friday, weighed down by Tesla and other technology-related stocks after a solid jobs report torpedoed recent optimism that the Federal Reserve might let up its aggressive ...</p>\n\n<a href=\"https://www.streetinsider.com/ETFs/S%26P+500+ends+down+as+jobs+data+rekindles+rate+hike+fear/20422400.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.streetinsider.com/ETFs/S%26P+500+ends+down+as+jobs+data+rekindles+rate+hike+fear/20422400.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153913928","content_text":"TheS&P500 ended lower on Friday, weighed down by Tesla and other technology-related stocks after a solid jobs report torpedoed recent optimism that the Federal Reserve might let up its aggressive campaign to reign in decades-high inflation.Data showed U.S. employers hired far more workers than expected in July, the 19th straight month of payrolls expansion, with the unemployment rate falling to a pre-pandemic low of 3.5%.The report added to recent data painting an upbeat picture of the world's largest economy after it contracted in the first half of the year. That deflated investors' expectations that the Fed might let up in its series of rate hikes aimed at cooling the economy.\"This is all about the Fed. A very strong jobs report like we had puts pressure on the Fed to tighten for longer,\" said Adam Sarhan, chief executive of 50 Park Investments. \"The market is scared the Fed is going to overshoot again. If they tighten too sharply and too long, that's going to cause a hard landing, a deep recession.\"Tesla tumbled 6.6% and weighed heavily on the S&P 500 and Nasdaq. Facebook-owner Meta Platforms lost 2% and Amazon fell 1.2%, also pulling down the index.U.S. Treasury yields climbed as odds increased of a 75-basis-point interest rate hike in September. That helped bank stocks, withJPMorganrising 3%, and helping the Dow Jones Industrial Average stay in positive territory.Focus now shifts to inflation data due next week, with U.S. annual consumer prices expected to jump by 8.7% in July after a 9.1% rise in June.Several policymakers have this week stuck to an aggressive policy tightening stance until they see strong and long-lasting evidence that inflation was trending toward the Fed's 2% goal.Surging inflation, the war in Ukraine, Europe's energy crisis and COVID-19 flare-ups in China have rattled investors this year.A largely upbeat second-quarter earnings season has helped the S&P 500 bounce back by about 13% from its mid-June lows after a rough first-half performance.The S&P 500 declined 0.16% to end the session at 4,145.19 points.The Nasdaq declined 0.50% to 12,657.56 points, while the Dow Jones Industrial Average rose 0.23% to 32,803.47 points.For the week, the S&P 500 rose 0.4%, the Dow fell 0.1% and the Nasdaq added 2.2%.Lyft Inc surged almost 17% after the ride-hailing firm forecast an adjusted operating profit of $1 billion for 2024 after posting record quarterly earnings.Advancing issues outnumbered falling ones within the S&P 500 by a 1.3-to-1 ratio.The S&P 500 posted four new highs and 30 new lows; the Nasdaq recorded 60 new highs and 38 new lows.Volume on U.S. exchanges was relatively light, with 10.6 billion shares traded, compared to an average of 10.8 billion shares over the previous 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837328499,"gmtCreate":1629858492411,"gmtModify":1676530154093,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Good perspective.","listText":"Good perspective.","text":"Good perspective.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/837328499","repostId":"1180783116","repostType":4,"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902064450,"gmtCreate":1659615382872,"gmtModify":1705982180747,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Buy more please Auntie Cathy!&nbsp;[LOL]&nbsp;[smile]&nbsp;","listText":"Buy more please Auntie Cathy!&nbsp;[LOL]&nbsp;[smile]&nbsp;","text":"Buy more please Auntie Cathy! [LOL] [smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902064450","repostId":"2256275479","repostType":4,"repost":{"id":"2256275479","pubTimestamp":1659625409,"share":"https://ttm.financial/m/news/2256275479?lang=&edition=fundamental","pubTime":"2022-08-04 23:03","market":"us","language":"en","title":"Cathie Wood Went Bargain Shopping, 3 Stocks She Bought Hand Over Fist Last Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2256275479","media":"Motley Fool","summary":"There are always bargains to be had if you just know where to look.","content":"<html><head></head><body><p>Cathie Wood closed out July on a buying spree. The co-founder and CEO of ARK Investment Management was combing through the second-quarter earnings reports of beaten-down stocks last week, and some of her picks might surprise you.</p><p>So what did she buy? Wood&#39;s exchange-traded funds (ETFs) added to existing stakes in <b>Roku</b>, <b>Shopify</b>, and <b>Teladoc</b>. Let&#39;s see if we can figure out what she sees in these former highfliers that have been abandoned by many investors.</p><h2><a href=\"https://laohu8.com/S/ROKU\">Roku</a></h2><p>There&#39;s no question that streaming video growth has hit a speed bump in recent months, as people headed back out into the world after enduring pandemic-related restrictions. Yet cord-cutting remains at near-epidemic proportions, and viewers will need to get their entertainment fix somewhere, which suggests that the growth of streaming media is far from over.</p><p>Roku has slumped 82% from its all-time high reached in mid-2021. However, the falling stock price doesn&#39;t mean its growth streak is over. Roku&#39;s revenue rose 18% year over year in its latest quarter, though it swung to a loss, spooking investors.</p><p>Streaming hours and active accounts grew 19% and 14%, respectively, continuing Roku&#39;s unbroken growth streak. Overlooked by investors was the company&#39;s average revenue per user (ARPU), which climbed 21%. This means Roku is making more from each successive viewer and suggests that once growth inevitably accelerates, profitability will surge.</p><p>Roku is the industry leader in a growing market, and while it has fallen on tough times, the future remains bright, which likely contributed to Wood&#39;s decision to buy shares even as the stock slid.</p><h2><a href=\"https://laohu8.com/S/SHOP\">Shopify</a></h2><p>Another stock that&#39;s been left for dead by investors is Shopify. Investors have convinced themselves that e-commerce growth has peaked, sending Shopify shares down roughly 77% from its high hit late last year.</p><p>Yet even as Shopify stock has plunged, growth has trudged higher. In Q2, revenue climbed 16% year over year, even in the face of tough comps, though expenses weighed on the bottom line. Shopify announced a series of cost-cutting measures -- including lay-offs -- that should help it return to profitability.</p><p>While online retail growth has hit a speed bump, it&#39;s far from over. In fact, in the 10 years prior to the pandemic, e-commerce sales more than doubled, growing from roughly 4% of total retail to nearly 10%. This suggests the pause in digital sales growth is merely temporary.</p><p>As the leading provider of tools that help merchants join the e-commerce revolution, Shopify is well positioned to benefit from this ongoing trend, which is why Wood continues to buy shares.</p><h2><a href=\"https://laohu8.com/S/TDOC\">Teladoc</a></h2><p>There&#39;s no doubt that the adoption of telehealth has slowed, weighing on Teladoc&#39;s stock price in the process, which is now down 76% from its peak reached early last year. That doesn&#39;t mean its growth is over, which is why Wood has been buying Teladoc shares by the fistful.</p><p>Q2 revenue grew 18% year over year, and while its losses mounted, much of that was the result of non-cash goodwill impairment charges related to its purchase of Livongo Health. Perhaps more importantly, total patient visits grew by 31% year over year, while its chronic care patients climbed 13%.</p><p>The ease and convenience of telemedicine hasn&#39;t changed, and patients who have used virtual consultations to meet with doctors and other medical professionals will continue to do so, though growth may come at a slower pace. Teladoc expects total visits of roughly 19 million in 2022, resulting in revenue growth of about 21% at the midpoint of its guidance. Given the write-offs, it&#39;s doubtful the company will be profitable this year, but that thing they say in the exercise community applies just as well to the investing experience. No pain, no gain! Teladoc will get back to making profits in the long run, so investors should pounce while shares are cheap.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Went Bargain Shopping, 3 Stocks She Bought Hand Over Fist Last Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Went Bargain Shopping, 3 Stocks She Bought Hand Over Fist Last Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-04 23:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/08/04/cathie-wood-went-bargain-shopping-for-3-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood closed out July on a buying spree. The co-founder and CEO of ARK Investment Management was combing through the second-quarter earnings reports of beaten-down stocks last week, and some of ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/08/04/cathie-wood-went-bargain-shopping-for-3-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc","TDOC":"Teladoc Health Inc.","SHOP":"Shopify Inc"},"source_url":"https://www.fool.com/investing/2022/08/04/cathie-wood-went-bargain-shopping-for-3-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2256275479","content_text":"Cathie Wood closed out July on a buying spree. The co-founder and CEO of ARK Investment Management was combing through the second-quarter earnings reports of beaten-down stocks last week, and some of her picks might surprise you.So what did she buy? Wood's exchange-traded funds (ETFs) added to existing stakes in Roku, Shopify, and Teladoc. Let's see if we can figure out what she sees in these former highfliers that have been abandoned by many investors.RokuThere's no question that streaming video growth has hit a speed bump in recent months, as people headed back out into the world after enduring pandemic-related restrictions. Yet cord-cutting remains at near-epidemic proportions, and viewers will need to get their entertainment fix somewhere, which suggests that the growth of streaming media is far from over.Roku has slumped 82% from its all-time high reached in mid-2021. However, the falling stock price doesn't mean its growth streak is over. Roku's revenue rose 18% year over year in its latest quarter, though it swung to a loss, spooking investors.Streaming hours and active accounts grew 19% and 14%, respectively, continuing Roku's unbroken growth streak. Overlooked by investors was the company's average revenue per user (ARPU), which climbed 21%. This means Roku is making more from each successive viewer and suggests that once growth inevitably accelerates, profitability will surge.Roku is the industry leader in a growing market, and while it has fallen on tough times, the future remains bright, which likely contributed to Wood's decision to buy shares even as the stock slid.ShopifyAnother stock that's been left for dead by investors is Shopify. Investors have convinced themselves that e-commerce growth has peaked, sending Shopify shares down roughly 77% from its high hit late last year.Yet even as Shopify stock has plunged, growth has trudged higher. In Q2, revenue climbed 16% year over year, even in the face of tough comps, though expenses weighed on the bottom line. Shopify announced a series of cost-cutting measures -- including lay-offs -- that should help it return to profitability.While online retail growth has hit a speed bump, it's far from over. In fact, in the 10 years prior to the pandemic, e-commerce sales more than doubled, growing from roughly 4% of total retail to nearly 10%. This suggests the pause in digital sales growth is merely temporary.As the leading provider of tools that help merchants join the e-commerce revolution, Shopify is well positioned to benefit from this ongoing trend, which is why Wood continues to buy shares.TeladocThere's no doubt that the adoption of telehealth has slowed, weighing on Teladoc's stock price in the process, which is now down 76% from its peak reached early last year. That doesn't mean its growth is over, which is why Wood has been buying Teladoc shares by the fistful.Q2 revenue grew 18% year over year, and while its losses mounted, much of that was the result of non-cash goodwill impairment charges related to its purchase of Livongo Health. Perhaps more importantly, total patient visits grew by 31% year over year, while its chronic care patients climbed 13%.The ease and convenience of telemedicine hasn't changed, and patients who have used virtual consultations to meet with doctors and other medical professionals will continue to do so, though growth may come at a slower pace. Teladoc expects total visits of roughly 19 million in 2022, resulting in revenue growth of about 21% at the midpoint of its guidance. Given the write-offs, it's doubtful the company will be profitable this year, but that thing they say in the exercise community applies just as well to the investing experience. No pain, no gain! Teladoc will get back to making profits in the long run, so investors should pounce while shares are cheap.","news_type":1},"isVote":1,"tweetType":1,"viewCount":391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902062671,"gmtCreate":1659615085595,"gmtModify":1705982177005,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Buy more please Auntie Cathy.","listText":"Buy more please Auntie Cathy.","text":"Buy more please Auntie Cathy.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902062671","repostId":"2256275479","repostType":4,"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814632948,"gmtCreate":1630811166584,"gmtModify":1676530398994,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Good one.","listText":"Good one.","text":"Good one.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/814632948","repostId":"1157895022","repostType":4,"repost":{"id":"1157895022","pubTimestamp":1630810619,"share":"https://ttm.financial/m/news/1157895022?lang=&edition=fundamental","pubTime":"2021-09-05 10:56","market":"us","language":"en","title":"Beat the market with this quant system that’s very bullish on stocks at record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1157895022","media":"MarketWatch","summary":"Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do ","content":"<blockquote>\n <b>Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.</b>\n</blockquote>\n<p>Imagine you had a money-making machine to harvest gains in the stock market while you sat back to enjoy life.</p>\n<p>That’s everyone’s dream, right? Investor Vance Howard thinks he’s found it.</p>\n<p>Howard and his small army of computer programmers atHoward Capital Managementin Roswell, Ga., have a quantitative system that posts great returns.</p>\n<p>His HCM Tactical Growth Fund&nbsp;HCMGX,+0.35%beats its Russell 1000&nbsp;benchmark index and large-blend fund category by 8.5-10.4 percentage points annualized over the past five years, according to Morningstar. That is no small feat, and not only because it has to overcome a 2.22% fee. Beating the market is simply not easy. His HCM Dividend Sector PlusHCMQX,-0.05%) and HCM Income PlusHCMLX,+0.30%funds post similar outperformance.</p>\n<p>There are drawbacks, which I detail below. (Among them: Potentially long stretches of underperformance and regular tax bills.) But first, what can we learn from this winner?</p>\n<p>So-called quants never share all the details of their proprietary systems, but Howard shares a lot, as you’ll see. And this Texas rancher has a lot of good advice based on “horse sense” — not surprising, given his infectious passion for the markets, and his three decades of experience as a pro.</p>\n<p>Here are five lessons, 12 exchange traded funds (ETFs) and four stocks to consider, from a recent interview with him.</p>\n<p><b>Lesson #1: Don’t be emotional</b></p>\n<p>It’s no surprise so many people do poorly in the market. Evolution has programmed us to fail. For survival, we’ve learned to run from things that frightens us. And crave more of things that are pleasurable — like sweets or fats to store calories ahead of what might be a long stretch without food. But in the market, acting on the emotions of fear and greed invariably make us do the wrong thing at the wrong time. Sell at the bottom, buy at the top.</p>\n<p>Likewise, we’re programmed to believe being with the crowd brings safety. If you’re a zebra on the Savanna, you are more likely to get picked off by a predator if you go it alone. The problem here is being part of a crowd — and crowd psychology — dumb us down to a purely emotional level. This is why people in crowds do terrible things they would never do on their own. It doesn’t matter how smart you are. When you join a crowd, you lose a lot of IQ points. Base emotions take over.</p>\n<p>To do well in the market, you have to counteract these tendencies. “One of the biggest mistakes individual investors and money managers make is getting emotional,” says Howard. “Let your emotions go.”</p>\n<p><b>Lesson #2: Have a system and stick to it</b></p>\n<p>To exorcise emotion, have a system. “And don’t second guess it,” says Howard. “This keeps you from letting the pandemic or Afghanistan scare you out of the market.” He calls his system the HCM-BuyLine. It is basically a momentum and trend-following system — which often works well in the markets.</p>\n<p>The HCM-BuyLine basically works like this. First, rather than use the S&amp;P 500SPX,-0.03%or the Dow Jones Industrial AverageDJIA,-0.21%,Howard blends several stock indices to create his own index. Then he uses a moving average that tells him whether the market is in an uptrend or downtrend.</p>\n<p>When the moving average drops 3.5%, he sells 35%. If it drops 6.5%, he sells another 35%. He rarely goes to 100% cash.</p>\n<p>“If the BuyLine is positive, we will stay long no matter what,” he says. “We take all the emotion out of the equation by letting the math decide.”</p>\n<p>Right now, it’s bullish. (More on this below.)</p>\n<p>Your system also has to tell you when to get back in.</p>\n<p>“That’s where most people screw up,” he says. “They get out of the market, and they don’t know when to get back in.” The HCM-BuyLine gives a buy signal when his custom index trades above its moving average for six consecutive sessions, and then goes on to trade above the high hit during those six days.</p>\n<p>You don’t need a system that calls exact market tops or bottoms. Instead, the BuyLine keeps Howard out of down markets 85% of the time, and in for 85% of the good times.</p>\n<p>“If we can do that consistently, we have superior returns and a less stressful life,” he says. “Being all in during a bad tape is no fun.”</p>\n<p>His system is slow to get him out of the market, but quick to get him back in. Not even a 10% correction will necessarily move him out. He’s often buying those pullbacks. Getting back in fast makes sense, because recoveries off bottoms tend to happen fast.</p>\n<p>“The HCM-BuyLine takes all the emotion out of the process,” says Howard.</p>\n<p><b>Lesson #3: Don’t fight the tape</b></p>\n<p>This concept is one of the core pieces of wisdom from Marty Zweig’s classic book, “Winning on Wall Street.”</p>\n<p>“You have to stay on the right side of market,” agrees Howard. “If you try to trade long in a bad market, it is painful.”</p>\n<p>In other words, don’t try to be a hero.</p>\n<p>“Sometimes, not losing money is where you want to be,” he says.</p>\n<p>Likewise, don’t turn cautious just because the market hits new highs — like now. You should love new highs, because it is a sign of market strength that may likely endure.</p>\n<p><b>Lesson #4: Keep it simple</b></p>\n<p>As you’ll see below, Howard doesn’t use esoteric instruments such as derivatives, swaps or index options. He doesn’t even trade foreign stocks or currencies. This is refreshing for individual investors, because we have a harder time accessing those tools.</p>\n<p>“You don’t have to trade crazy stuff,” he says. “You can trade plain-vanilla ETFs and beat everybody out there.”</p>\n<p><b>Lesson #5: How to trade the current market</b></p>\n<p>First, be long.</p>\n<p>“The HCM-BuyLine is very positive. We are 100% in,” says Howard. “The market is broadening out. It is getting pretty exciting. We do not see it turn around any time soon. We are buying pullbacks.”</p>\n<p>One bullish signal is all the cash on the sidelines. “If there is any relief in Covid, we may see a big rally. We may end up with a great fall [season].”</p>\n<p>Howard uses momentum indicators to select stocks and ETFs, too. For sectors he favors the following.</p>\n<p>He likes health care, tradable through the iShares US HealthcareIYH,-0.04%and ProShares Ultra Health CareRXL,+0.12%ETFs. He’s turning more bullish on biotech, which he plays via the iShares Biotechnology ETFIBB,-0.11%.</p>\n<p>He likes consumer discretionary tradable through the iShares US Consumer ServicesIYC,-0.30%,and airlines via US Global JetsJETS,-1.17%.He also likes tech exposure via the Invesco QQQ TrustQQQ,+0.31%,iShares US TechnologyIYW,+0.50%and&nbsp;iShares SemiconductorSOXX,+0.75%.</p>\n<p>He likes small-caps via the Vanguard Small-Cap Growth Index FundVBK,+0.07%.And convertible bonds via SPDR Bloomberg Barclays Convertible SecuritiesCWB,+0.64%and iShares Convertible BondICVT,+0.37%.</p>\n<p>As for individual names, he singles out MicrosoftMSFT,-0.00%and AppleAAPL,+0.42%in tech, as well as Amazon.comAMZN,+0.43%and TeslaTSLA,+0.16%.</p>\n<p>Also consider Howard’s two ETFs: The HCM Defender 100 IndexQQH,+0.62%and HCM Defender 500 IndexLGH,+1.32%.</p>\n<p>He prefers to add to holdings on 1%-3% dips.</p>\n<p><b>A few drawbacks</b></p>\n<p>His HCM Tactical Growth fund has a history of posting two-year stretches of underperformance of 1.5% to 8.8%, since it was launched in 2015. The fund then came roaring back to net the very positive five-year outperformance cited above. Investing in his system can require patience.</p>\n<p>Every manager, including Warren Buffett, can have a stretch of underperformance, says Howard.</p>\n<p>“We are in the odds game,” he says. “Even in the odds game, you can have a bad hand or two thrown at you.”</p>\n<p>Another challenge is the high turnover, which is 140% a year for Tactical Growth. This means Uncle Sam takes a big cut in the good years. So if you buy Howard’s funds, you may want to do so in a tax-protected account.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beat the market with this quant system that’s very bullish on stocks at record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeat the market with this quant system that’s very bullish on stocks at record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-05 10:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.\n\nImagine you had a money-making ...</p>\n\n<a href=\"https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157895022","content_text":"Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.\n\nImagine you had a money-making machine to harvest gains in the stock market while you sat back to enjoy life.\nThat’s everyone’s dream, right? Investor Vance Howard thinks he’s found it.\nHoward and his small army of computer programmers atHoward Capital Managementin Roswell, Ga., have a quantitative system that posts great returns.\nHis HCM Tactical Growth Fund HCMGX,+0.35%beats its Russell 1000 benchmark index and large-blend fund category by 8.5-10.4 percentage points annualized over the past five years, according to Morningstar. That is no small feat, and not only because it has to overcome a 2.22% fee. Beating the market is simply not easy. His HCM Dividend Sector PlusHCMQX,-0.05%) and HCM Income PlusHCMLX,+0.30%funds post similar outperformance.\nThere are drawbacks, which I detail below. (Among them: Potentially long stretches of underperformance and regular tax bills.) But first, what can we learn from this winner?\nSo-called quants never share all the details of their proprietary systems, but Howard shares a lot, as you’ll see. And this Texas rancher has a lot of good advice based on “horse sense” — not surprising, given his infectious passion for the markets, and his three decades of experience as a pro.\nHere are five lessons, 12 exchange traded funds (ETFs) and four stocks to consider, from a recent interview with him.\nLesson #1: Don’t be emotional\nIt’s no surprise so many people do poorly in the market. Evolution has programmed us to fail. For survival, we’ve learned to run from things that frightens us. And crave more of things that are pleasurable — like sweets or fats to store calories ahead of what might be a long stretch without food. But in the market, acting on the emotions of fear and greed invariably make us do the wrong thing at the wrong time. Sell at the bottom, buy at the top.\nLikewise, we’re programmed to believe being with the crowd brings safety. If you’re a zebra on the Savanna, you are more likely to get picked off by a predator if you go it alone. The problem here is being part of a crowd — and crowd psychology — dumb us down to a purely emotional level. This is why people in crowds do terrible things they would never do on their own. It doesn’t matter how smart you are. When you join a crowd, you lose a lot of IQ points. Base emotions take over.\nTo do well in the market, you have to counteract these tendencies. “One of the biggest mistakes individual investors and money managers make is getting emotional,” says Howard. “Let your emotions go.”\nLesson #2: Have a system and stick to it\nTo exorcise emotion, have a system. “And don’t second guess it,” says Howard. “This keeps you from letting the pandemic or Afghanistan scare you out of the market.” He calls his system the HCM-BuyLine. It is basically a momentum and trend-following system — which often works well in the markets.\nThe HCM-BuyLine basically works like this. First, rather than use the S&P 500SPX,-0.03%or the Dow Jones Industrial AverageDJIA,-0.21%,Howard blends several stock indices to create his own index. Then he uses a moving average that tells him whether the market is in an uptrend or downtrend.\nWhen the moving average drops 3.5%, he sells 35%. If it drops 6.5%, he sells another 35%. He rarely goes to 100% cash.\n“If the BuyLine is positive, we will stay long no matter what,” he says. “We take all the emotion out of the equation by letting the math decide.”\nRight now, it’s bullish. (More on this below.)\nYour system also has to tell you when to get back in.\n“That’s where most people screw up,” he says. “They get out of the market, and they don’t know when to get back in.” The HCM-BuyLine gives a buy signal when his custom index trades above its moving average for six consecutive sessions, and then goes on to trade above the high hit during those six days.\nYou don’t need a system that calls exact market tops or bottoms. Instead, the BuyLine keeps Howard out of down markets 85% of the time, and in for 85% of the good times.\n“If we can do that consistently, we have superior returns and a less stressful life,” he says. “Being all in during a bad tape is no fun.”\nHis system is slow to get him out of the market, but quick to get him back in. Not even a 10% correction will necessarily move him out. He’s often buying those pullbacks. Getting back in fast makes sense, because recoveries off bottoms tend to happen fast.\n“The HCM-BuyLine takes all the emotion out of the process,” says Howard.\nLesson #3: Don’t fight the tape\nThis concept is one of the core pieces of wisdom from Marty Zweig’s classic book, “Winning on Wall Street.”\n“You have to stay on the right side of market,” agrees Howard. “If you try to trade long in a bad market, it is painful.”\nIn other words, don’t try to be a hero.\n“Sometimes, not losing money is where you want to be,” he says.\nLikewise, don’t turn cautious just because the market hits new highs — like now. You should love new highs, because it is a sign of market strength that may likely endure.\nLesson #4: Keep it simple\nAs you’ll see below, Howard doesn’t use esoteric instruments such as derivatives, swaps or index options. He doesn’t even trade foreign stocks or currencies. This is refreshing for individual investors, because we have a harder time accessing those tools.\n“You don’t have to trade crazy stuff,” he says. “You can trade plain-vanilla ETFs and beat everybody out there.”\nLesson #5: How to trade the current market\nFirst, be long.\n“The HCM-BuyLine is very positive. We are 100% in,” says Howard. “The market is broadening out. It is getting pretty exciting. We do not see it turn around any time soon. We are buying pullbacks.”\nOne bullish signal is all the cash on the sidelines. “If there is any relief in Covid, we may see a big rally. We may end up with a great fall [season].”\nHoward uses momentum indicators to select stocks and ETFs, too. For sectors he favors the following.\nHe likes health care, tradable through the iShares US HealthcareIYH,-0.04%and ProShares Ultra Health CareRXL,+0.12%ETFs. He’s turning more bullish on biotech, which he plays via the iShares Biotechnology ETFIBB,-0.11%.\nHe likes consumer discretionary tradable through the iShares US Consumer ServicesIYC,-0.30%,and airlines via US Global JetsJETS,-1.17%.He also likes tech exposure via the Invesco QQQ TrustQQQ,+0.31%,iShares US TechnologyIYW,+0.50%and iShares SemiconductorSOXX,+0.75%.\nHe likes small-caps via the Vanguard Small-Cap Growth Index FundVBK,+0.07%.And convertible bonds via SPDR Bloomberg Barclays Convertible SecuritiesCWB,+0.64%and iShares Convertible BondICVT,+0.37%.\nAs for individual names, he singles out MicrosoftMSFT,-0.00%and AppleAAPL,+0.42%in tech, as well as Amazon.comAMZN,+0.43%and TeslaTSLA,+0.16%.\nAlso consider Howard’s two ETFs: The HCM Defender 100 IndexQQH,+0.62%and HCM Defender 500 IndexLGH,+1.32%.\nHe prefers to add to holdings on 1%-3% dips.\nA few drawbacks\nHis HCM Tactical Growth fund has a history of posting two-year stretches of underperformance of 1.5% to 8.8%, since it was launched in 2015. The fund then came roaring back to net the very positive five-year outperformance cited above. Investing in his system can require patience.\nEvery manager, including Warren Buffett, can have a stretch of underperformance, says Howard.\n“We are in the odds game,” he says. “Even in the odds game, you can have a bad hand or two thrown at you.”\nAnother challenge is the high turnover, which is 140% a year for Tactical Growth. This means Uncle Sam takes a big cut in the good years. So if you buy Howard’s funds, you may want to do so in a tax-protected account.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832183047,"gmtCreate":1629598238989,"gmtModify":1676530075985,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Good run","listText":"Good run","text":"Good run","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/832183047","repostId":"2161745814","repostType":4,"repost":{"id":"2161745814","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1629493200,"share":"https://ttm.financial/m/news/2161745814?lang=&edition=fundamental","pubTime":"2021-08-21 05:00","market":"hk","language":"en","title":"S&P 500 hasn't fallen 5% from a peak in nearly 200 sessions--what that tells market historians","url":"https://stock-news.laohu8.com/highlight/detail?id=2161745814","media":"Dow Jones","summary":"It is an unbearable lightness of being for the S&P 500 index.\nThe broad-market measure of a basket o","content":"<p>It is an unbearable lightness of being for the S&amp;P 500 index.</p>\n<p>The broad-market measure of a basket of 500 U.S. stocks has been preternaturally resistant to pullbacks of late, despite concerns about the spread of the highly transmissible delta variant of COVID-19 and worries that the Federal Reserve’s strategy to reduce its bond purchases may be ill-timed.</p>\n<p>Yet, the S&amp;P 500 indexSPX,+0.81%has seen a largely uninterrupted ascent to such a degree that Friday marked the 200th session without a drawdown of 5% or more from a recent peak, making the current stretch of levitation the longest such since 2016, when the market went 404 sessions without falling by at least 5% peak to trough.</p>\n<p><img src=\"https://static.tigerbbs.com/d5d7a23827730d58001a0b40420acd79\" tg-width=\"981\" tg-height=\"437\" width=\"100%\" height=\"auto\">It is extremely rare for the market to enjoy such a period of relative effervescence. Indeed, such lengthy stretches without a 5% pullback or better have occurred on only eight occasions in the S&amp;P 500 index, the attached table shows.</p>\n<p>There clearly are reasons why the market is clambering higher in the recovery from COVID, set againsta daunting wall of worry. Investors are jockeying between areas of the market that are expected to boost revenue and profit faster than the rest of the pack and those that are beaten down and might benefit from a fuller economic rebound from coronavirus.</p>\n<p>Buying on Monday helped the Dow Jones Industrial AverageDJIA,+0.65%and the S&amp;P 500 indexSPX,+0.81%produce their 35th and 49th record all-time closing highs of 2021, respectively. Meanwhile, the Nasdaq Composite IndexCOMP,+1.19%stands a little over 2.5% from its record high put in on Aug. 5.</p>\n<p>There is, of course, a sense that the party for stocks can’t last forever.</p>\n<p>So, how does the market tend to perform in period after such a protracted bullish run?</p>\n<p>The data set is very small but the S&amp;P 500 has mostly climbed on a median basis, falling 1.2% in the following year but producing a median gain of 17.6% in a two-year period and 55% in the ensuing five-year period. The mean average return is better, showing a gain of 6.5%, 27.4% and 64%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/d556c67fc01e330a57abb4c65802c29d\" tg-width=\"964\" tg-height=\"626\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 hasn't fallen 5% from a peak in nearly 200 sessions--what that tells market historians</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 hasn't fallen 5% from a peak in nearly 200 sessions--what that tells market historians\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-21 05:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>It is an unbearable lightness of being for the S&amp;P 500 index.</p>\n<p>The broad-market measure of a basket of 500 U.S. stocks has been preternaturally resistant to pullbacks of late, despite concerns about the spread of the highly transmissible delta variant of COVID-19 and worries that the Federal Reserve’s strategy to reduce its bond purchases may be ill-timed.</p>\n<p>Yet, the S&amp;P 500 indexSPX,+0.81%has seen a largely uninterrupted ascent to such a degree that Friday marked the 200th session without a drawdown of 5% or more from a recent peak, making the current stretch of levitation the longest such since 2016, when the market went 404 sessions without falling by at least 5% peak to trough.</p>\n<p><img src=\"https://static.tigerbbs.com/d5d7a23827730d58001a0b40420acd79\" tg-width=\"981\" tg-height=\"437\" width=\"100%\" height=\"auto\">It is extremely rare for the market to enjoy such a period of relative effervescence. Indeed, such lengthy stretches without a 5% pullback or better have occurred on only eight occasions in the S&amp;P 500 index, the attached table shows.</p>\n<p>There clearly are reasons why the market is clambering higher in the recovery from COVID, set againsta daunting wall of worry. Investors are jockeying between areas of the market that are expected to boost revenue and profit faster than the rest of the pack and those that are beaten down and might benefit from a fuller economic rebound from coronavirus.</p>\n<p>Buying on Monday helped the Dow Jones Industrial AverageDJIA,+0.65%and the S&amp;P 500 indexSPX,+0.81%produce their 35th and 49th record all-time closing highs of 2021, respectively. Meanwhile, the Nasdaq Composite IndexCOMP,+1.19%stands a little over 2.5% from its record high put in on Aug. 5.</p>\n<p>There is, of course, a sense that the party for stocks can’t last forever.</p>\n<p>So, how does the market tend to perform in period after such a protracted bullish run?</p>\n<p>The data set is very small but the S&amp;P 500 has mostly climbed on a median basis, falling 1.2% in the following year but producing a median gain of 17.6% in a two-year period and 55% in the ensuing five-year period. The mean average return is better, showing a gain of 6.5%, 27.4% and 64%, respectively.</p>\n<p><img src=\"https://static.tigerbbs.com/d556c67fc01e330a57abb4c65802c29d\" tg-width=\"964\" tg-height=\"626\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","OEX":"标普100","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF","SH":"标普500反向ETF",".SPX":"S&P 500 Index","SDS":"两倍做空标普500ETF","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161745814","content_text":"It is an unbearable lightness of being for the S&P 500 index.\nThe broad-market measure of a basket of 500 U.S. stocks has been preternaturally resistant to pullbacks of late, despite concerns about the spread of the highly transmissible delta variant of COVID-19 and worries that the Federal Reserve’s strategy to reduce its bond purchases may be ill-timed.\nYet, the S&P 500 indexSPX,+0.81%has seen a largely uninterrupted ascent to such a degree that Friday marked the 200th session without a drawdown of 5% or more from a recent peak, making the current stretch of levitation the longest such since 2016, when the market went 404 sessions without falling by at least 5% peak to trough.\nIt is extremely rare for the market to enjoy such a period of relative effervescence. Indeed, such lengthy stretches without a 5% pullback or better have occurred on only eight occasions in the S&P 500 index, the attached table shows.\nThere clearly are reasons why the market is clambering higher in the recovery from COVID, set againsta daunting wall of worry. Investors are jockeying between areas of the market that are expected to boost revenue and profit faster than the rest of the pack and those that are beaten down and might benefit from a fuller economic rebound from coronavirus.\nBuying on Monday helped the Dow Jones Industrial AverageDJIA,+0.65%and the S&P 500 indexSPX,+0.81%produce their 35th and 49th record all-time closing highs of 2021, respectively. Meanwhile, the Nasdaq Composite IndexCOMP,+1.19%stands a little over 2.5% from its record high put in on Aug. 5.\nThere is, of course, a sense that the party for stocks can’t last forever.\nSo, how does the market tend to perform in period after such a protracted bullish run?\nThe data set is very small but the S&P 500 has mostly climbed on a median basis, falling 1.2% in the following year but producing a median gain of 17.6% in a two-year period and 55% in the ensuing five-year period. The mean average return is better, showing a gain of 6.5%, 27.4% and 64%, respectively.","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894582074,"gmtCreate":1628839616898,"gmtModify":1676529870978,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Wait till it has bounced back up.","listText":"Wait till it has bounced back up.","text":"Wait till it has bounced back up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/894582074","repostId":"2158225219","repostType":4,"repost":{"id":"2158225219","pubTimestamp":1628819431,"share":"https://ttm.financial/m/news/2158225219?lang=&edition=fundamental","pubTime":"2021-08-13 09:50","market":"us","language":"en","title":"Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?","url":"https://stock-news.laohu8.com/highlight/detail?id=2158225219","media":"Motley Fool","summary":"One particular group of stocks is overrepresented among the exchange's biggest losers this year. That's an important detail.","content":"<p>If you're like many other investors, your search for bargain stocks starts with names that have been severely sold off. As well it should. The market is capable of going to extremes at times, devaluing names only to revalue them again just a short time later. You know the practice by its more familiar name, \"buying the dip.\" The bigger the dip, the better the bargain.</p>\n<p>As veteran investors can attest, however, a stock that's been up-ended isn't inherently a stock that's ready for a recovery. Sometimes, a steep sell-off is exactly what's implied.</p>\n<p>It's the dilemma anyone looking at this year's biggest losers among Nasdaq-listed stocks is facing, as usual. This time around though, there's an additional curious nuance. Most of these losers are in the exact same industry, and have been crushed for the exact same reasons.</p>\n<h2>One too many headwinds</h2>\n<p>For the record, excluding always-volatile small caps and micro caps, the five biggest losers on the Nasdag this year are (with losses respectively ranging from -65% to -56%) <a href=\"https://laohu8.com/S/POSH\">Poshmark, Inc.</a>, <a href=\"https://laohu8.com/S/ACAD\">ACADIA Pharmaceuticals</a>, <a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a>, <a href=\"https://laohu8.com/S/ARVL\">Arrival</a>, and <a href=\"https://laohu8.com/S/FOLD\">Amicus Therapeutics</a>.</p>\n<p><b>It's difficult to ignore that biotech stocks feature prominently among these most severe laggards.</b></p>\n<p>And this theme only solidifies as you look deeper into 2021's worst-to-date performers among the Nasdaq's larger listings. Biotech names <a href=\"https://laohu8.com/S/SRPT\">Sarepta Therapeutics</a> and <a href=\"https://laohu8.com/S/TGTX\">TG Therapeutics</a> claim the sixth and seventh spots from the bottom, down 54% and 53% so far this year.</p>\n<p><b>Can there be a rebound for biotech stocks?</b></p>\n<p>It's a detail worth noting as odds are good that any recovery any of them manage to make from here is likely going to be part of a groupwide rebound. Such a rebound won't be particularly easy to come by, however, for a handful of reasons.</p>\n<p>Chief among reasons it will be hard to recover is sheer circumstance.</p>\n<p><img src=\"https://static.tigerbbs.com/7c680dca85708f2eaaee3bcb174a2eff\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Vaccine race:</b> You may recall a bunch of biotech stocks logged stellar performance around the middle of last year, shortly after the COVID-19 contagion turned into a global pandemic. The world didn't know which player would come up with a vaccine or treatment (or even a test) first, so investors simply made bets on a variety of names in the business... including many of the ones listed above. Once <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>, <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>, and&nbsp;<a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a> essentially won that race though, investors lost the will to stick with other entries.</p>\n<p>The dynamic has been particularly painful for shareholders of <a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a>, which just went public in December, seemingly to capitalize on the vaccine mania that had already peaked. Its shares are now below their IPO price of $17, and well below the stock's December peak near $72.</p>\n<p><b>Recent FTC stance on pharmaceutical mergers</b>: That's not the only thing working against the industry, however, and smaller biotech names in particular. Much of the entire sector's recent weakness also coincides with the Federal Trade Commission's (FTC) creation of a global task force assembled in March to \"build a new approach to pharmaceutical mergers.\"</p>\n<p>It's not clear how much authority this working group will wield. But, in that the announcement made a point of mentioning \"skyrocketing drug prices and ongoing concerns about anticompetitive conduct in the industry,\" it is clear there's a brewing risk to the entire business of drug development.</p>\n<p>It's also worth mentioning that more than a few biotech start-ups are tacitly hoping to get bought out at their inception, with investors quietly hoping for the same. This is going to be a more difficult, less rewarding prospect if the FTC-led efforts are effective.</p>\n<p><b>Legislative changes and regulations:</b> Then there's the even-more philosophical argument that the entire industry is on the verge of running back into the legislative and regulatory buzz saw.</p>\n<p>It's a recurring story. The business usually emerges from such scrutiny unscathed. Indeed, the fact that not many people balked at the $56,000 price tag for <a href=\"https://laohu8.com/S/BIIB\">Biogen</a> recently approved Alzheimer's drug Aduhelm tacitly says drugmakers remain completely in control of their pricing policies... even prices charged to Medicare.</p>\n<p>With a new presidential administration in place, though, proposed legislation like the bills Senator Bernie Sanders and other Democrats unveiled in March -- aimed at lowering drug prices for the government as well as for individuals -- are given another fighting chance.</p>\n<p>Sooner or later, one of these will slip through. And then another. And then another. It's a risk to many smaller biotech developers, which frequently count on high prices for relatively unique therapies.</p>\n<h2>To buy, or not to buy?</h2>\n<p>Fine, but don't these huge pullbacks still make these particular biotech names compelling prospects despite all their challenges?</p>\n<p>Not really.</p>\n<p>To be fair, there's nothing about any cost-curbing prospect or a now-meaningless coronavirus vaccine race that supersedes any of these aforementioned companies' stories. And in the world of biotech, stories about a drug's potential readily substitute for sales and earnings.</p>\n<p>Identifying winning drug developments and looking past misguided research and development is still a key part of the biotech investing game. As of right now, however, the collective overhang is just too much for even the very best biotech stories to break through.</p>\n<p>Some breakthroughs will happen, mind you. We just don't know which names will be the ones best positioned to overcome the headwind and adequately reward shareholders for the risk being taken. It's a headwind that could blow for a few more weeks, if not a few more months.</p>\n<p>The bigger takeaway: Always keep tabs on the market environment and its key themes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 09:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/12/is-it-time-to-buy-5-of-the-nasdaqs-worst-performin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you're like many other investors, your search for bargain stocks starts with names that have been severely sold off. As well it should. The market is capable of going to extremes at times, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/12/is-it-time-to-buy-5-of-the-nasdaqs-worst-performin/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"POSH":"Poshmark, Inc.","ACAD":"阿卡迪亚","FOLD":"爱美医疗","ABCL":"AbCellera Biologics"},"source_url":"https://www.fool.com/investing/2021/08/12/is-it-time-to-buy-5-of-the-nasdaqs-worst-performin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158225219","content_text":"If you're like many other investors, your search for bargain stocks starts with names that have been severely sold off. As well it should. The market is capable of going to extremes at times, devaluing names only to revalue them again just a short time later. You know the practice by its more familiar name, \"buying the dip.\" The bigger the dip, the better the bargain.\nAs veteran investors can attest, however, a stock that's been up-ended isn't inherently a stock that's ready for a recovery. Sometimes, a steep sell-off is exactly what's implied.\nIt's the dilemma anyone looking at this year's biggest losers among Nasdaq-listed stocks is facing, as usual. This time around though, there's an additional curious nuance. Most of these losers are in the exact same industry, and have been crushed for the exact same reasons.\nOne too many headwinds\nFor the record, excluding always-volatile small caps and micro caps, the five biggest losers on the Nasdag this year are (with losses respectively ranging from -65% to -56%) Poshmark, Inc., ACADIA Pharmaceuticals, AbCellera Biologics, Arrival, and Amicus Therapeutics.\nIt's difficult to ignore that biotech stocks feature prominently among these most severe laggards.\nAnd this theme only solidifies as you look deeper into 2021's worst-to-date performers among the Nasdaq's larger listings. Biotech names Sarepta Therapeutics and TG Therapeutics claim the sixth and seventh spots from the bottom, down 54% and 53% so far this year.\nCan there be a rebound for biotech stocks?\nIt's a detail worth noting as odds are good that any recovery any of them manage to make from here is likely going to be part of a groupwide rebound. Such a rebound won't be particularly easy to come by, however, for a handful of reasons.\nChief among reasons it will be hard to recover is sheer circumstance.\n\nImage source: Getty Images.\nVaccine race: You may recall a bunch of biotech stocks logged stellar performance around the middle of last year, shortly after the COVID-19 contagion turned into a global pandemic. The world didn't know which player would come up with a vaccine or treatment (or even a test) first, so investors simply made bets on a variety of names in the business... including many of the ones listed above. Once Pfizer, Moderna, Inc., and Johnson & Johnson essentially won that race though, investors lost the will to stick with other entries.\nThe dynamic has been particularly painful for shareholders of AbCellera Biologics, which just went public in December, seemingly to capitalize on the vaccine mania that had already peaked. Its shares are now below their IPO price of $17, and well below the stock's December peak near $72.\nRecent FTC stance on pharmaceutical mergers: That's not the only thing working against the industry, however, and smaller biotech names in particular. Much of the entire sector's recent weakness also coincides with the Federal Trade Commission's (FTC) creation of a global task force assembled in March to \"build a new approach to pharmaceutical mergers.\"\nIt's not clear how much authority this working group will wield. But, in that the announcement made a point of mentioning \"skyrocketing drug prices and ongoing concerns about anticompetitive conduct in the industry,\" it is clear there's a brewing risk to the entire business of drug development.\nIt's also worth mentioning that more than a few biotech start-ups are tacitly hoping to get bought out at their inception, with investors quietly hoping for the same. This is going to be a more difficult, less rewarding prospect if the FTC-led efforts are effective.\nLegislative changes and regulations: Then there's the even-more philosophical argument that the entire industry is on the verge of running back into the legislative and regulatory buzz saw.\nIt's a recurring story. The business usually emerges from such scrutiny unscathed. Indeed, the fact that not many people balked at the $56,000 price tag for Biogen recently approved Alzheimer's drug Aduhelm tacitly says drugmakers remain completely in control of their pricing policies... even prices charged to Medicare.\nWith a new presidential administration in place, though, proposed legislation like the bills Senator Bernie Sanders and other Democrats unveiled in March -- aimed at lowering drug prices for the government as well as for individuals -- are given another fighting chance.\nSooner or later, one of these will slip through. And then another. And then another. It's a risk to many smaller biotech developers, which frequently count on high prices for relatively unique therapies.\nTo buy, or not to buy?\nFine, but don't these huge pullbacks still make these particular biotech names compelling prospects despite all their challenges?\nNot really.\nTo be fair, there's nothing about any cost-curbing prospect or a now-meaningless coronavirus vaccine race that supersedes any of these aforementioned companies' stories. And in the world of biotech, stories about a drug's potential readily substitute for sales and earnings.\nIdentifying winning drug developments and looking past misguided research and development is still a key part of the biotech investing game. As of right now, however, the collective overhang is just too much for even the very best biotech stories to break through.\nSome breakthroughs will happen, mind you. We just don't know which names will be the ones best positioned to overcome the headwind and adequately reward shareholders for the risk being taken. It's a headwind that could blow for a few more weeks, if not a few more months.\nThe bigger takeaway: Always keep tabs on the market environment and its key themes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811345164,"gmtCreate":1630292389458,"gmtModify":1676530259389,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811345164","repostId":"1187925169","repostType":4,"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888353722,"gmtCreate":1631442809766,"gmtModify":1676530549105,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Oracle is bullish","listText":"Oracle is bullish","text":"Oracle is bullish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888353722","repostId":"1160482100","repostType":4,"repost":{"id":"1160482100","pubTimestamp":1631413030,"share":"https://ttm.financial/m/news/1160482100?lang=&edition=fundamental","pubTime":"2021-09-12 10:17","market":"us","language":"en","title":"3 Upcoming Earnings Reports to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=1160482100","media":"InvestorPlace","summary":"These three companies could move the market when they release earnings reports this week\nSource: Shu","content":"<p>These three companies could move the market when they release earnings reports this week</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d277b8ff1b6b6711ba0749313119f04\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Shutterstock</span></p>\n<p>It’s the tail end of earnings season with only a few notable companies left to issue earnings reports. In the coming weeks, we’ll get results from a few influential and closely followed companies, including a major technology firm and homebuilder. These earnings will bring to a close what has been, by all accounts, a&nbsp;stellar season&nbsp;of corporate results.</p>\n<p>Over the past several months, we have witnessed a parade of better-than-expected quarterly earnings from both small and large companies. The strong earnings are expected to continue through the rest of this year, with&nbsp;<b>Wells Fargo</b>(NYSE:<b><u>WFC</u></b>)&nbsp;recently forecasting&nbsp;that strong financial results will lift the S&amp;P 500 index a further 8% through the end of December.</p>\n<p>Here are four companies with earnings reports the week of September 13:</p>\n<ul>\n <li><b>Oracle</b>(NYSE:<b><u>ORCL</u></b>)</li>\n <li><b>Lennar</b>(NYSE:<b><u>LEN</u></b>)</li>\n <li><b>Birks Group</b>(NYSEAMERICAN:<b><u>BGI</u></b>)</li>\n</ul>\n<p><b>Oracle (ORCL)</b></p>\n<p>The lone large cap technology company reporting earnings in the week ahead is database and enterprise software giant Oracle. On Sept. 13, the Austin, Texas-based company will report its fiscal first quarter 2022 results. Any beat to the upside should add to ORCL stock’s&nbsp;already considerable momentum.</p>\n<p>Year-to-date the company’s shares are up almost 40% at a Sept. 10 opening price of just under $90. The latest rally, which has been ongoing since mid-June, could get a second wind if Oracle manages to impress Wall Street with its latest numbers.</p>\n<p>Wall Street is looking for Oracle to report revenues of $9.77 billion and earnings per share of $0.97 for its first quarter. Analysts expect the company’s&nbsp;earnings to be powered&nbsp;by its cloud infrastructure business, which has taken off this year as a growing number of businesses accelerate their migration to cloud computing and storage. Oracle is also getting a boost from the rollout of 5G wireless networking. In its previous quarterly earnings report, Oracle was expected to&nbsp;announce EPS&nbsp;of $1.31 per share, but ended up reporting $1.54 per share instead, beating the street by an impressive 17.56%.</p>\n<p><b>Lennar (LEN)</b></p>\n<p>Lennar, the largest homebuilder in the U.S., reports its latest earnings on Sept. 20. And, as always, investors, analysts and economists will be watching closely for signs of health in the American housing market.</p>\n<p>LEN stock has done well this year, rising 33% since January to now trade at just over $100 a share. However, the stock has moved in fits and starts in recent months. In the last 30 days, Lennar’s share price has&nbsp;pulled back 4%&nbsp;from its 52-week high of $110.61. With a trailing price-to-earnings ratio of just 9.79, Lennar’s stock looks undervalued.</p>\n<p>Lennar has been benefitting this year from the booming housing market that has been fueled by low interest rates and a desire for people to upgrade their home during the pandemic. Wall Street certainly has high expectations for the company’s upcoming earnings.</p>\n<p>Analysts are looking for&nbsp;Lennar to report revenues of $6.86 billion, which would be a 17% increase from a year earlier. Earnings per share are forecast to come in at $3.28. With interest rates expected to remain at rock bottom lows until at least the middle of next year, Lennar and its shareholders should continue to reap rewards.</p>\n<p><b>Birks Group (BGI)</b></p>\n<p>Now for a&nbsp;penny stock&nbsp;that has shown real moxie this year. Montreal, Quebec-based jeweler Birks Group is currently estimated to report its earnings on Sept. 16, and the results could extend what has already been&nbsp;an incredible year for BGI stock.</p>\n<p>Since January, Birks Group share price has grown 187%, rising from $0.84 to its current level of $2.50. In March of this year, the stock was as high as $5.43 before retreating by 54% to its current price. The growth (and volatility) in the stock price can be attributed to gradually improving sales as it reopened most of its 29 retail outlets in its native Canada and the U.S.</p>\n<p>Birks should perform well in the final months of the year and during the holidays, which is traditionally the strongest sales period for its jewelry and gift items. Owing to its penny stock status, there are no real analyst forecasts for the company’s upcoming earnings. However, in its&nbsp;previous quarter, the company announced net sales of $143.1 million, a decrease of 15.5% from the year earlier period. Any improvement on the earnings front could help BGI stock rise further and, perhaps, remain above the $5 per share penny stock threshold.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Upcoming Earnings Reports to Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Upcoming Earnings Reports to Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/earnings-reports-to-watch-next-week/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>These three companies could move the market when they release earnings reports this week\nSource: Shutterstock\nIt’s the tail end of earnings season with only a few notable companies left to issue ...</p>\n\n<a href=\"https://investorplace.com/earnings-reports-to-watch-next-week/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEN":"莱纳建筑公司","ORCL":"甲骨文","BGI":"Birks Group Inc."},"source_url":"https://investorplace.com/earnings-reports-to-watch-next-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160482100","content_text":"These three companies could move the market when they release earnings reports this week\nSource: Shutterstock\nIt’s the tail end of earnings season with only a few notable companies left to issue earnings reports. In the coming weeks, we’ll get results from a few influential and closely followed companies, including a major technology firm and homebuilder. These earnings will bring to a close what has been, by all accounts, a stellar season of corporate results.\nOver the past several months, we have witnessed a parade of better-than-expected quarterly earnings from both small and large companies. The strong earnings are expected to continue through the rest of this year, with Wells Fargo(NYSE:WFC) recently forecasting that strong financial results will lift the S&P 500 index a further 8% through the end of December.\nHere are four companies with earnings reports the week of September 13:\n\nOracle(NYSE:ORCL)\nLennar(NYSE:LEN)\nBirks Group(NYSEAMERICAN:BGI)\n\nOracle (ORCL)\nThe lone large cap technology company reporting earnings in the week ahead is database and enterprise software giant Oracle. On Sept. 13, the Austin, Texas-based company will report its fiscal first quarter 2022 results. Any beat to the upside should add to ORCL stock’s already considerable momentum.\nYear-to-date the company’s shares are up almost 40% at a Sept. 10 opening price of just under $90. The latest rally, which has been ongoing since mid-June, could get a second wind if Oracle manages to impress Wall Street with its latest numbers.\nWall Street is looking for Oracle to report revenues of $9.77 billion and earnings per share of $0.97 for its first quarter. Analysts expect the company’s earnings to be powered by its cloud infrastructure business, which has taken off this year as a growing number of businesses accelerate their migration to cloud computing and storage. Oracle is also getting a boost from the rollout of 5G wireless networking. In its previous quarterly earnings report, Oracle was expected to announce EPS of $1.31 per share, but ended up reporting $1.54 per share instead, beating the street by an impressive 17.56%.\nLennar (LEN)\nLennar, the largest homebuilder in the U.S., reports its latest earnings on Sept. 20. And, as always, investors, analysts and economists will be watching closely for signs of health in the American housing market.\nLEN stock has done well this year, rising 33% since January to now trade at just over $100 a share. However, the stock has moved in fits and starts in recent months. In the last 30 days, Lennar’s share price has pulled back 4% from its 52-week high of $110.61. With a trailing price-to-earnings ratio of just 9.79, Lennar’s stock looks undervalued.\nLennar has been benefitting this year from the booming housing market that has been fueled by low interest rates and a desire for people to upgrade their home during the pandemic. Wall Street certainly has high expectations for the company’s upcoming earnings.\nAnalysts are looking for Lennar to report revenues of $6.86 billion, which would be a 17% increase from a year earlier. Earnings per share are forecast to come in at $3.28. With interest rates expected to remain at rock bottom lows until at least the middle of next year, Lennar and its shareholders should continue to reap rewards.\nBirks Group (BGI)\nNow for a penny stock that has shown real moxie this year. Montreal, Quebec-based jeweler Birks Group is currently estimated to report its earnings on Sept. 16, and the results could extend what has already been an incredible year for BGI stock.\nSince January, Birks Group share price has grown 187%, rising from $0.84 to its current level of $2.50. In March of this year, the stock was as high as $5.43 before retreating by 54% to its current price. The growth (and volatility) in the stock price can be attributed to gradually improving sales as it reopened most of its 29 retail outlets in its native Canada and the U.S.\nBirks should perform well in the final months of the year and during the holidays, which is traditionally the strongest sales period for its jewelry and gift items. Owing to its penny stock status, there are no real analyst forecasts for the company’s upcoming earnings. However, in its previous quarter, the company announced net sales of $143.1 million, a decrease of 15.5% from the year earlier period. Any improvement on the earnings front could help BGI stock rise further and, perhaps, remain above the $5 per share penny stock threshold.","news_type":1},"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943231640,"gmtCreate":1679471024381,"gmtModify":1679471026355,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","text":"$Credit Bureau Asia(TCU.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943231640","isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9902799117,"gmtCreate":1659751187241,"gmtModify":1703750140836,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902799117","repostId":"1118235746","repostType":4,"repost":{"id":"1118235746","pubTimestamp":1659750084,"share":"https://ttm.financial/m/news/1118235746?lang=&edition=fundamental","pubTime":"2022-08-06 09:41","market":"us","language":"en","title":"AMD Remains on Track to Meet Its Targets, Says Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1118235746","media":"TipRanks","summary":"Advanced Micro Devices (AMD)could not deliver the by now almost customary beat-and-raise in its late","content":"<div>\n<p>Advanced Micro Devices (AMD)could not deliver the by now almost customary beat-and-raise in its latest quarterly statement, even as the company delivered record revenues driven by a big growth for its...</p>\n\n<a href=\"https://www.tipranks.com/news/article/strong-earnings-confirm-the-bull-thesis-on-amd-stock/\">Web Link</a>\n\n</div>\n","source":"lsy1606183248679","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD Remains on Track to Meet Its Targets, Says Analyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD Remains on Track to Meet Its Targets, Says Analyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-06 09:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/article/strong-earnings-confirm-the-bull-thesis-on-amd-stock/><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Advanced Micro Devices (AMD)could not deliver the by now almost customary beat-and-raise in its latest quarterly statement, even as the company delivered record revenues driven by a big growth for its...</p>\n\n<a href=\"https://www.tipranks.com/news/article/strong-earnings-confirm-the-bull-thesis-on-amd-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"source_url":"https://www.tipranks.com/news/article/strong-earnings-confirm-the-bull-thesis-on-amd-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118235746","content_text":"Advanced Micro Devices (AMD)could not deliver the by now almost customary beat-and-raise in its latest quarterly statement, even as the company delivered record revenues driven by a big growth for its server sales.The chip giant generated sales of $6.55 billion, amounting to a 70.1% year-over-year increase and just edging ahead of the $6.53 billion consensus estimate. For the bottom-line, adj. EPS hit $1.05, 2 cents above the $1.03 predicted by Wall Street. Data center was the star of the show, as revenue surged by 83% from the same period last year.AMD stock recently overtook its once far bigger rival Intel’s market cap, and as an indication of how AMD is trouncing it in the data-center market, Intel recently reported a 16% year-over-year sales decline for its data-center server segment.However, marring the occasion, the top-line outlook just missed Street expectations. Due to the ongoing weakness in PCs, although AMD managed to meet its target for Q3 sales between $6.5 billion to $6.9 billion, the figure came in shy of the analysts’ call for $6.84 billion. Nevertheless, AMD stuck to its revenue outlook of $26 billion to $26.6 billion for the full year.Scanning the print, Susquehanna analyst Christopher Roll and notes the company remains on track to meet its targets, even in the face of a “challenging PC environment.”“Despite the slowing PC backdrop, AMD reiterated their full-year outlook, underpinned by strength in server,” the 5-star analyst said. “While we had previewed a 3Q miss and cut estimates, guidance was only a tad below and certainly ‘better than feared’. More importantly, management reiterated their full year guidance of $26.3 billion. That said, it creates a lofty goal for 4Q (even with the 14th week), particularly considering uncertainty around the PC market and traditional decline in consoles.”All told, there’s no change to Rolland’s Positive (i.e., Buy) rating or $115 price target. The implication for investors? Upside of 12% from the current trading price. Most analysts are backing AMD’s continued success, although not all are believers. The stock claims a Moderate Buy consensus rating, based on 19 Buys, 8 Holds and 1 Sell. Given the average price target stands at $123.50, there’s room for ~21% share appreciation in the year ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943231801,"gmtCreate":1679470999104,"gmtModify":1679471001884,"author":{"id":"3582116885862894","authorId":"3582116885862894","name":"EdTigor","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582116885862894","authorIdStr":"3582116885862894"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/TCU.SI\">$Credit Bureau Asia(TCU.SI)$ &nbsp;</a>","text":"$Credit Bureau Asia(TCU.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943231801","isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}